Podcasts about responsible use

In this episode of Behind the Genes, we explore how Artificial Intelligence (AI) is being applied in genomics through cross-sector collaborations. Genomics England and InstaDeep are working together on AI and machine learning-related projects to accelerate cancer research and drive more personalised healthcare. Alongside these scientific advances, our guests also discuss the ethical, societal and policy challenges associated with the use of AI in genomics, including data privacy and genomic discrimination. Our guests ask what responsible deployment of AI in healthcare should look like and how the UK can lead by example. Our host, Francisco Azuaje, Director of Bioinformatics Genomics England is joined by Dr Rich Scott, Chief Executive Officer at Genomics England Karim Beguir - Chief Executive Officer at InstaDeep Harry Farmer – Senior Researcher at Ada Lovelace Institute If you enjoyed today's conversation, please like and share wherever you listen to your podcasts. And for more on AI in genomics, tune in to our earlier episode: Can Artificial Intelligence Accelerate the Impact of Genomics? "In terms of what AI's actually doing and what it's bringing, it's really just making possible things that we've been trying to do in genomics for some time, making these things easier and cheaper and in some cases viable. So really it's best to see it as an accelerant for genomic science; it doesn't present any brand-new ethical problems, instead what it's doing is taking some fairly old ethical challenges and making these things far more urgent."   You can download the transcript, or read it below.   Francisco: Welcome to Behind the Genes. [Music plays] Rich: The key is to deliver what we see at the heart of our mission which is bringing the potential of genomic healthcare to everyone.  We can only do that by working in partnership.  We bring our expertise and those unique capabilities.  It's about finding it in different ways, in different collaborations, that multiplier effect, and it's really exciting.  And I think the phase we're in at the moment in terms of the use of AI in genomics is we're still really early in that learning curve. [Music plays] Francisco: My name is Francisco Azuaje, and I am Director of Bioinformatics at Genomics England.  On today's episode I am joined by Karim Beguir, CEO of InstaDeep, a pioneering AI company, Harry Farmer, Senior Researcher at the Ada Lovelace Institute, and Rich Scott, CEO of Genomics England.  Today we will explore how Genomics England is collaborating with InstaDeep to harness the power of AI in genomic research.  We will also dive into the critical role of ethical considerations in the development and application of AI technologies for healthcare.  If you've enjoyed today's episode, please like, share on wherever you listen to your podcasts. [Music plays] Let's meet our guests. Karim: Hi Francisco, it's a pleasure to be here.  I am the Co-Founder and CEO of InstaDeep and the AI arm of BioNTech Group, and I'm also an AI Researcher. Harry: I'm Harry Farmer, I'm a Senior Researcher at the Ada Lovelace Institute, which is a think-tank that works on the ethical and the societal implications of AI, data and other emerging digital technologies, and it's a pleasure to be here. Rich: Hi, it's great to be here with such a great panel.  I'm Rich Scott, I'm the CEO of Genomics England. Francisco: Thank you all for joining us.  I am excited to explore this intersection of AI and genomics with all of you.  To our listeners, if you wish to hear more about AI in genomics, listen to our previous podcast episode, ‘Can Artificial Intelligence Accelerate the Impact of Genomics', which is linked in this podcast description. Let's set the stage with what is happening right now, Rich, there have been lots of exciting advances in AI and biomedical research but in genomics it's far more than just hype, can you walk us through some examples of how AI is actually impacting genomic healthcare research? Rich: Yeah, so, as you say, Francisco, it is a lot more than hype and it's really exciting.  I'd also say that we're just at the beginning of a real wave of change that's coming.  So while AI is already happening today and driving our thinking, really we're at the beginning of a process.  So when you think about how genomics could impact healthcare and people's health in general, what we're thinking about is genomics potentially playing a routine part in up to half of all healthcare encounters, we think, based on the sorts of differences it could make in different parts of our lives and our health journey.  There are so many different areas where AI, we expect, will help us on that journey.  So thinking about, for example, how we speed up the interpretation of genetic information through to its use and the simple presentation of how to use that in life, in routine healthcare, through to discovery of new biomarkers or classification that might help us identify the best treatment for people.  Where it's making a difference already today is actually all of those different points.  So, for example, there's some really exciting work we're doing jointly with Karim and team looking at how we might use classification of the DNA sequence of tumours to help identify what type of tumour - a tumour that we don't know where it's come from, so what we call a ‘cancer of unknown primary' - to help in that classification process.  We're also working with various different people who are interested in classification for treatment and trials, but there's also lots in between recognising patterns of genomic data together with other complex data.  So we've been doing a lot of work bringing image data together with genomic data and other health data so that you can begin to recognise patterns that we couldn't even dream of.  Doing that hand in hand with thinking about what patients and participants want and expect, how their data is used and how their information is held, bringing it all together and understanding how this works, the evidence that we need before we can decide that a particular approach is one that policymakers, people in healthcare want to use, is all part of the conversation. Francisco: Thank you, Rich, for speaking of cutting-edge AI applications and InstaDeep.  Karim, could you give us a glimpse into your work and particularly how your technologies are tackling some of the biggest challenges in genomic research? Karim: Absolutely, and I think what's exciting is we've heard from Rich and, you know, this is like the genomics expertise angle of things and I come from the AI world and so do most of the InstaDeep team.  And really what's fascinating is this intersection that is being extremely productive at the moment where technologies that have been developed for like multiple AI applications turn out to be extremely useful in understanding genomic sequences.  This is a little bit, our journey, Francisco.  Back in 2021/2022 we started working on the very intriguing question at the time of could we actually understand better genomic sequences with the emerging technologies of NLP, natural language processing.  And you have to put this in context, this was before even the word ‘generative AI' was coined, this was before ChatGPT, but we had sort of like an intuition that there was a lot of value in deploying this technology.  And so my team, sort of like a team of passionate experts in research and engineering of AI, we tackled this problem and started working on it and the result of this work was our nucleotide transformer model which we have open sourced today; it's one of the most downloaded, most popular models in genomics.  And what's interesting is we observed that simply using the technologies of what we call ‘self-supervised learning' or ‘unsupervised learning' could actually help us unlock a lot of patterns. As we know, most of genomics information is poorly understood and this is a way actually, with using the AI tool, to get some sense of the structure that's there. So how do we do this?  We basically mask a few aspects of the sequence and we ask the system to figure them out.  And so this is exactly how you teach a system to learn English, you know, you are teaching it to understand the language of genomics, and, incredibly, this approach when done at scale - and we train a lot on the NVIDIA Cambridge-1 supercomputer – allows you to have results and performances that are matching multiple specialised models.  So until then genomics and use of machine learning for genomics was for a particular task, I would have developed a specific model using mostly supervised learning, which is, I am showing you a few examples, and then channelled these examples and tried to match that, and so essentially you had one model per task.  What's really revolutionary in this new paradigm of AI is that you have a single model trained at very largescale, the AI starts to understand the patterns, and this means that very concretely we can work with our partners to uncover fascinating relationships that were previously poorly understood.  And so there is a wealth of potential that we are exploring together and it's a very exciting time. Francisco: What you're describing really highlights both the potential and the opportunities but also the responsibility we have with these powerful tools, its power, and this brings up some important ethical considerations.  And we have Harry…  Harry, we have talked about ethics frameworks in research for decades but AI seems to be rewriting the rulebook.  For your work at the Ada Lovelace Institute what makes AI fundamentally different from previous technologies when it comes to ethical considerations and how does this reshape our approach to ensuring these powerful tools benefit society as a whole? Harry: So I think when you are considering these sorts of ethical questions and these sorts of ethical challenges posed by AI and genomics it really depends on the sort of deployment that you're looking at.  From the conversation we've had so far, I think what's been hinted at is some of the diversity of applications that you might be using AI for within the context of genomics and healthcare.  So I think there's obviously big advances that have been alluded to in things like drug discovery, in things like cancer and cancer diagnosis, also these advances around gene editing, all of which have been on steroids, by artificial intelligence and particularly machine learning and deep learning. The area that we have been looking at at the Ada Lovelace Institute, and this was a project that we were doing in collaboration with the NCOB, the Nuffield Council on Bioethics, was looking at what we were calling ‘AI-powered genomic health prediction', which is very related to a technique called ‘polygenic scoring', for those who might be interested.  And that's looking at the emerging ability to make predictions about people's future health on the basis of their DNA, and it was thinking about what that ability might mean for UK society and also for how we are thinking about and delivering healthcare in the UK. Now, thinking about what the ethical challenges might be for that, I think you need to think about what specifically AI is bringing to that technique, so what it's bringing to genomic health prediction.  I think with some of the other deployments, the list of things that AI is bringing is quite similar, so it's helping with data collection and processing, so speeding up and automating data collection and preparation processes that otherwise are quite slow and very labour-intensive.  AI's also helping with the analysis of genomic and phenotype data, so helping us to understand the associations between different genomic variations and between observable traits, and this is something which without AI can often be prohibitively complex to do, and it's also sometimes suggested that on the deployment end AI can be a tool that can help us use genomic insight in healthcare more widely.  So one example of this might be using an AI chat bot to explain to a patient the results of a genomic test.  That's something that's only been mooted and I don't think there are current examples of that at the moment but that's one of the downstream applications of AI in the context of genomics. So in terms of what AI's actually doing and what it's bringing, it's really just making possible things that we've been trying to do in genomics for some time, making these things easier and cheaper and in some cases viable.  So really it's best to see it as an accelerant for genomic science; it doesn't present any brand-new ethical problems, instead what it's doing is taking some fairly old ethical challenges and making these things far more urgent.  So in terms of what those problems actually are, some of the big ones will be around privacy and surveillance, genomic health predictions produce a lot of intimate sensitive data about people and generating those insights requires the collection and the storage and the processing of a lot of very sensitive data as well.  We also have issues related to privacy around genomic discrimination, so this is the worry that people will be treated differently and in some cases unfairly on the basis of health predictions made about them.  And one of the really typical examples here is the worry that people might face higher insurance costs if they're found through genomic testing to be more likely to develop particular diseases over their life course. And then you also have a bunch of issues and questions which are more structural, so these are questions about how the availability of this kind of insight into people's future health might change or put pressure on existing ways of thinking about health and thinking about healthcare and some extreme cases thinking about the social contract.  So these are questions like does the viability of genomic health prediction lead to a radically more preventative approach to healthcare and what might this mean for what the state demands of you as a user of healthcare and as a recipient of that.  And there are also some important questions about the practicalities of delivering genomic medicine in the NHS, so questions like how does the NHS retain control and sovereignty over genomic analysis and data capacities, how do we test their efficacy at a public health level, and also – and this is something that we might talk about a bit later – what's the best deployment model for these capacities.  So that's some of the ethical and I think policy challenges that we need to be dealing with in this space. Francisco: Thank you, Harry.  And those principles you have outlined provide a solid foundation for discussing different types of applications. [Music plays] Let's talk about the InstaDeep and Genomics England partnership that is investigating the application of InstaDeep's powerful foundation model, the nucleotide transformer, and other cutting edge techniques to address several challenges in cancer research.  I have the privilege of working closely with this partnership and the potential here is immense.  Karim, could you break down for our listeners what you are working on together and what innovations you are aiming for? Karim: Absolutely, Francisco.  Actually, we are very excited by the collaboration with Genomics England.  Genomics England not only has one of the best data assets in the world when it comes to genomics, like a very well curated dataset but also a wealth of expertise on these topics, and on my side the InstaDeep team brings fundamental knowhow of machine learning models but also, as you mentioned, like powerful developed models already, such as our nucleotide transformer and others.  The culture of InstaDeep has always been to build AI that benefits everyone – this is literally in our mission – and so in particular, specifically on like current topics, really like the goal is to try to identify partners between genomic sequences of patients and the particular phenotypes or approaches.  And one of the key projects, which I mentioned that, is the one of cancer of unknown primary origin.  So when you have situations where you are not sure where a particular cancer emerged from it is critical to be able to extract this information to have the best potential care, and this is actually something where understanding of genomic sequences can bring this capability.  And so we've been getting some successful results in the collaboration but in many ways this is just the beginning.  What we are seeing is a great wealth of possibilities linking genotypes, so the information which is on the sequences themselves, the genomic sequences, and phenotypes, like the particular state of the patient, and the fact that the Genomics England team has those joint datasets creates incredible opportunities.  So we are looking at this really like identifying together what are the most useful ‘low-hanging fruits', if you want, in terms of like potentially improving a patient's care and moving forward from that. Francisco: And this collaborative approach you are describing raises questions about accelerating innovation in general.  When two organisations like Genomics England and InstaDeep come together it's like a multiplier effect in terms of expertise, data, and other resources.  Could you both share how this partnership is accelerating discoveries that might have taken years? Rich: Yeah, I mean, I think this…  Francisco, you frame it really nicely because this is what makes it so exciting to be in our position at Genomics England because what we do is we bring the particular understanding and expertise, digital infrastructure and custodianship of the National Genomic Research Library together, but actually the key is bringing the potential of genomic healthcare to everyone.  We can only do that by working in partnership, we bring our expertise and those capabilities.  And, as you say, it's about finding it in different ways, in different collaborations, that multiplier effect, and it's really exciting.  And I think the phase we're in at the moment in terms of the use of AI in genomics is we're still really early in that learning curve.  And so, as you've heard already through what Karim and I have said and also what Harry has said, there are multiple different aspects that we need to look at together, bringing different angles and understandings, and we see ourselves…  We often describe ourselves as a ‘data and evidence engine', that final word ‘evidence' is really important and it comes in the round.  So Harry really eloquently talked about a number of different considerations from an ethical perspective that need to be there.  What we need if we're going to move genomics forwards in terms of its potential to make a difference for people's lives, we need evidence around clinical efficacy of different approaches, that's absolutely a given and everyone always jumps at…  so it's almost first in line.  We need understanding about the health economics, you know, how much difference does it make for a particular investment, is it worth that investment.  Critically, it also is founded on, you know, how you might use this technology in different ways, how you use it in clinical pathways, you know, is it something that actually is addressing the particular questions which really hold back the delivery of better care.  Also in that evidence piece is an understanding of patients' and participants' expectations on how their data might be used, their expectations on privacy, the expectations that we have on understanding how equitable the use of a particular approach might be, or at least our understanding of how confident we are about the equity of the impact, and it's bringing together those different perspectives.  And that's one of the things that helps us construct the team at Genomics England so we have the expertise to help others access the data in the National Genomic Research Library for purposes our participants support but also help generate that sort of rounded package of evidence that will end up moving the dial.  So that it's not just about proving a cool widget, because that's great on its own, what drives Karim and the team is to make a difference in terms of outcomes, and that's exactly what drives us and our participants too. Francisco: And this and other partnership approaches brings up important questions about responsible innovation, and this naturally leads us to the next question for Harry, how do we harness these powerful tools when protecting our communities? Harry: Yeah, so if we are thinking about over-surveillance and the ways that vulnerable groups might be affected by the use of genomics and healthcare, I think we're talking about at least two different things here.  So one problems around the representativeness of data is it does lead to issues which you could classify as issues of differential accuracy.  So in the context of genomic prediction what you have is genomic predictive tools being more accurate for white Europeans and those with white European ancestry compared to other population groups.  And this is a product of the fact that genomic datasets and genomic predictions, the terminologies don't port well between different populations, which means if you train a genomic predictive tool on a bunch of people with white European ancestry the predictions you might make using that tool for other groups won't be as accurate as for the white Europeans.  And this can be actively harmful and dangerous for those in underrepresented groups because you are making predictions about people which just won't have the accuracy that you would expect in the context that you were deploying it. And I already mentioned this a bit in my previous answer, you have worries about discrimination, and there are a few different things here.  So with some historically marginalised groups and marginalised groups now there are longstanding historical sensitivities about being experimented on, about particular fears about eugenics and about being categorised in particular ways.  And it's worth saying here that there is obviously a racial dimension to this worry but I think there's also a class dimension, by which I mean you're far more vulnerable to being categorised unfavourably if you're poor or if you don't have a particular kind of status within society.  There is also within discrimination the idea that genomics might be used to explain away differences between different groups which in fact have a political or an economic basis.  So one example of this was during the COVID-19 pandemic, there were attempts by some commentators to explain away the fact that non-white communities had worse rates of mortality from COVID to try and attribute a genetic or a genomic basis to those differences rather than looking at some of the socioeconomic factors behind that.  So those are some worries as well. Now, when it comes to protecting particular groups I think there are a few things that can be done fairly straightforwardly.  So, one is work to improve the diversity and the representativeness of datasets.  Obviously, that's easier said than done, though it's a very clear thing that we can aspire towards and there is good work, I'm aware, that is going on in this space, some of which is being spearheaded by Genomics England, amongst other groups.  Another is just being very careful about how the results of population level genomic studies are communicated to avoid giving that impression of explaining away differences between different groups simply as things determined by genomics about which we can do nothing rather than things which have historical or socioeconomic bases.  But I also think the broader lesson is that some of these harms and these forms of discrimination are things that could theoretically affect anyone; they're not just limited to affecting marginalised groups. Genomic health predicting can produce bases for all of us to be discriminated against, things that have nothing to do with our race, our class, our sex or any other protected characteristic.  So I think there has to be thinking about how we establish or sure up more universal protections against genomic discrimination.  One thing that we can do here is simply stronger data protection law, and one of the things that we talk about in some of our reports is that how data protection law as it stands could do with being less ambiguous when it comes to how it treats genomic data and phenotype data produced as a result of genomic analysis. [Music plays] Francisco: Harry, you are in a unique position at the Ada Lovelace Institute where you bridge this gap between AI developers, researchers, policymakers and the public.  Your recent report on AI in genomics with the Nuffield Council on Bioethics offers an important blueprint for responsible AI innovation in general, so based on this cross-sector perspective, what guiding principles do we need to embrace as we navigate this intersection of AI and genomics? Harry: So I think in addition to the specific recommendations we set out in the final report of that work - which is called ‘Predicting the Future of Health' and which you can find on our website and also on the NCOB website – I think one of the biggest messages was the importance of finding a deployment model for genomic health prediction that respects that technology's strengths, what it can actually do, because there are limitations to this technology, and also which avoids circumstances in which the associated risks are difficult to deal with.  So another way of putting this is that we need a deployment model that, as well as making sure that we're ready to cope with the risks of genomic health prediction, the things like law, regulation and governance also proactively tries to design out some of those risks and finds ways of deploying this technology such that those risks don't present themselves in either as extreme a manner or don't present themselves in ways which makes them difficult to deal with. So one question that we posed in our research was whether some ways of integrating genomic health prediction may present more challenges regarding privacy, discrimination and then these other challenges that we'd identified around dependency and fragility and others. And having looked at some of the different broad approaches to using genomic health prediction within the NHS and within the UK's health system, we found that one presented by far fewest of the risks identified above, while still presenting some of the most certain benefits of genomic health prediction.  And this was using it really primarily as a targeted diagnostic tool - and this is a vision in which the NHS uses genomic health prediction quite sparingly in the first instance - and in situations to improve treatment and outcomes for those who are seriously ill or who have been identified as needing to take particular precautions regarding their health.  We think the more situational vision has a few advantages.  So one, is it allows patient and people using the health service to retain greater control over data.  We think that can also have a positive knock-on effect for worries about discrimination.  And here what you have is the absence of those pressures to share your data.  It means that it's easier for you as the user of the healthcare system to resist genomic discrimination simply by keeping your data private.  And there are some cases where that option… it shouldn't be the only option but where that option is really important. And then also one of the features of this vision is that the smaller scale of the use of genomic health prediction, presumed, can make outsourcing to third parties, which the NHS is probably likely to need to do in some cases.  It's also a vision, I think, that overall allows you to capture some of the more certain benefits to genomic health prediction which are about improvements to accuracy in predictions about people's future health at the margin, and therefore this is a deployment of this technology which is deploying it principally to people who will benefit and we know will benefit from marginal improvements in accuracy to predictions made about their future health rather than wanting to deploy those marginal improvements to the vast majority of the population where the benefit is less certain.  So this is a vision we hope sets out a way of getting some of the more certain benefits of this technology while minimising some of those broader more systemic risks. Francisco: Thank you, Harry.  Karim? Karim: Totally agree with Harry about the need for smart regulation in the field so that we make sure we have good uses of the technology but avoid the potential pitfalls.  I wanted to emphasise two points which I believe are important.  First, we are really in a fast-moving situation when we look at like AI progress.  We have seen incredible improvements over the last ten years and in particular what we call ‘artificial general intelligence', which is essentially systems that are matching human cognitive abilities, are now around the corner.  This might sound surprising but literally the last obstacles to reach AGI are being solved right now, and this means that in the next 12-24 months you will have systems that are incredibly capable.  So this emphasises the need for the type of measures and type of smart approach that Harry has described.  And I would say when you look at the intersection of AI and genomics this is a particularly important one and why it's the case, because so far in genomics our obstacle has not been data, it has been interpretation of a flood of data.  The progress that AI is making, like I just described now, means that very soon extraordinary capabilities will be available to improve patients' outcomes.  I want to inject a sense of how important is our conversation today, given what is happening, an exponential progress in AI, exponentially growing data in genomics and relatively exponential potential to build the technology for good.  But, like in other fields, we see that AI is an extremely powerful technology and we need to make sure it is used for good in fact and this is why the conversation that we have today is so important. Harry: Obviously I agree with the conclusion to all of this, is that we need to think very hard about the way that artificial intelligence and its deployment in healthcare and also just in many different walks of life is going to be affecting the way we think about public service delivery, affecting the way that we think about scientific development.  It's worth noting, though, that I think one of the biggest challenges from a policy perspective on artificial intelligence is being able to distinguish the wheat from the chaff.  There are obviously areas where AI has made huge and incredibly impressive progress over the past few years and where we reasonably expect that to continue over the next few years, but there are also areas where some of the stories being told about the capabilities of future systems probably won't be matched by the reality, but there is I think a really big and very live debate about exactly what we can reasonably expect from these technologies and therefore what the deployments of them are. Francisco: Thank you.  We are approaching the end of the episode and I'd like to conclude with a couple of questions.  Genomics England has built quite an ecosystem of industry partnerships, how do collaborations like the one with InstaDeep fit into your broader mission for the company? Rich: So linking this to the conversation that we've just been having, which is AI is making a real difference in terms of technologies that we can test, we can develop evidence on, and that is rightly creating excitement, I think our approach…  The expectation of our participants is that our role is to sit there and help people develop evidence and you can make judgments on policy based on those and that is what will drive adoption.  I think the thing that really excites me for the UK, most particularly in genomics, is our ability to be the place in the world where you can come with a new technology, whether it's genomic sequencing technology, whether it's a genomic AI approach to train that to develop evidence on its efficacy, and, if it's proven to be effective to be worth the bang for the buck to perform to the expectations that patients, the public, would have of it in terms of equity and so forth also to deploy it.  I think there is a real reason for excitement around that and it's a real opportunity that the government has highlighted and that we absolutely buy into that the UK can be the best place to do that for academics and for industry.  And our participants see real opportunity and are eager for that work to be done so that we have the evidence on which to decide what should be deployed and where.  We see opportunities in all sorts of different areas, so certainly in terms of drug discovery and all the way through to simplifying tasks which at the moment just limit the rate at which the existing uses of genomics in healthcare can happen. So I think there's opportunities across the whole length, if you like, the sort of end to end, and the breadth of opportunity, and industry, companies like InstaDeep and others that we work with, are really crucial to that.  And what we do is think about the digital infrastructure we need to, you know, have those teams able to interact with within the National Genomic Research Library carrying out their approved research projects.  Also what support they need, and that comes in different shapes and sizes, depending on the ask and also the company.  So sometimes sort of leaning in more, particularly at the start of programmes, to help people shape the question, working with our participants, thinking about the wider evidence that you might need, for example, those sort of things that Harry's touched on, but also thinking about what hands-on support companies need, because not every company is anywhere close to Karim and InstaDeep's expertise.  Sometimes this is also about supporting people to have some of those tools that they don't have or some of the knowhow that's very specific to areas of genomics, so it's absolutely crucial to it.  And I think that point of the UK being the place to come and develop that evidence in its full breadth so that policy decisions can be made not based on hype but on evidence in the round, on what will make a difference. Francisco: And, Karim, looking ahead, also in retrospect, what have been your key learnings about making this cross-sector partnership work? Karim: We live in an extraordinary time and I want to emphasise the potential of scientific discovery in the next two or three years.  AI is going to move from, let's say, digital style, you know, technologies like coding and maths towards more like science and biology.  In particular, genomics is going to be a fascinating area in terms of potential, and I agree with Rich and Harry, it's all in the end about proving on the ground the potential of those capabilities.  And at InstaDeep we are passionate about the tech – I think you might have felt that – but we're also passionate about the applications.  The best results come when you bring expertise from multiple domains; machine learning and AI experts will require the expertise of genomic experts, biologists, healthcare practitioners, to be able to translate the potential of those technologies in concrete outcomes.  And we've seen this on multiple successful projects we've done with Genomics England but really this suggests that we are going to have in the next 3-5 years way more progress than we had in the last five and really my wish is that collectively we seize this opportunity and we do it in a responsible and thoughtful manner. [Music plays] Francisco: We'll wrap up there.  Thank you to our guests, Karim Beguir, Harry Farmer and Rich Scott, for joining me today as we discuss the role of AI in genomics research.  If you wish to hear more like this, please subscribe to Behind the Genes on your favourite podcast app.  Thank you for listening.  I have been your host, Francisco Azuaje.  This podcast was edited by Bill Griffin at Ventoux Digital and produced by Naimah Callachand. [Music plays]    

Artificial Intelligence is seen as a critical tool for solving climate change. We talk about optimizing grids, accelerating material discovery, and predicting extreme weather.But can AI really help us solve the climate crisis faster than it contributes to it?Today I'm joined by three sharp thinkers in the world of climate:- Hampus Jakobsson: founding partner at Pale Blue Dot and a bullish believer in AI for climate- Pippa Gawley: founding partner at Zero Carbon Capital and a cautious observer of the AI hype- Matteo Turchetta: co-founder and CTO at KoraLabs and PhD in AI for sustainable agriculture from ETH ZürichTogether, we answer the question: Is AI a good thing for the climate?***We talk about: Why adding “AI” to your pitch won't save a climate startupHow smaller, smarter models could reduce emissionsWhether climate data is good enough to train real solutionsWhen AI crosses the line from helpful to harmfulHow small AI wins might unlock massive physical world impactWhen regulation makes sense, and when it stifles innovation… and more!***Where to find Hampus, Pippa & Matteo:Hampus | Pale Blue Dot | The DropPippa | Zero Carbon CapitalMatteo | KoraLabs***Timestamps:(00:00) Introduction (01:30) AI Solution Categories (03:57) Investor Skepticism (06:54) Practical Use Cases (12:30) Data Quality Matters (17:17) Environmental Impact of AI (23:05) Solving Real Problems (33:57) Accelerating Dirty Industries (40:05) Responsible Use of AI (46:06) Key Takeaways***Other episodes you might like: - How Climate Startups Get Their FIRST Investor***Sign up for my free newsletter: - VCo2 | The Climate Investing Podcast | Hugo Rauch | Substack This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit climateventuresvco2.substack.com

In a world where scientific progress holds the key to solving humanity's most pressing challenges, Henri Max Deda, co-founder of scienceOS.ai, shares his journey from molecular biologist to science communicator and entrepreneur. Speaking with Jo Havemann, Henri reflects on how his diverse background and a pivotal lecture on the “Network Effect” inspired him to co-create a platform that empowers researchers to collaborate and innovate more effectively. The realization that vast amounts of unpublished research data lead to redundant R&D spending became a driving force behind scienceOS, a tool initially designed for life science researchers but now serving a broader scientific community.Read more about this episode at https://access2perspectives.org/2025/07/a-conversation-with-henri-max-deda/ Find more podcast episodes here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://access2perspectives.org/conversations/⁠⁠⁠⁠Host:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Dr Jo Havemann⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ORCID iD ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠0000-0002-6157-1494 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Editing: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ebuka Ezeike⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Music:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Alex Lustig⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Kitty Kat ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠License:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Attribution 4.0 International (CC BY 4.0)   ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠At Access 2 Perspectives, we guide you in your complete research workflow toward state-of-the-art research practices and in full compliance with funding and publishing requirements. Leverage your research projects to higher efficiency and increased collaboration opportunities while fostering your explorative spirit and joy.Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://access2perspectives.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Erik Schwartz is a technologist and serial entrepreneur with over 20 years of experience in the tech sector, specialising in AI, information search and retrieval, and knowledge discovery. Erik is the Co-Founder and Chief AI Officer at Elysia.ai Labs. integrating Large Language Models (LLMs) and Generative AI into search technologies, offering automation, intelligent AI assistants, and multimodal AI experiences that help businesses unlock AI's full potential and achieve real operational outcomes.Read more about Erik Schwartz: https://businessabc.net/wiki/erik-schwartzErik Schwartz Interview Questions00:00- 1:57 Key highlights1:58- 05:59 Introduction05:00- 12:51 Erik's Background 11:00- 15:41 Erik's Career Evolution15:42- 21:03  Family Influence on Career Journey21:04- 29:09 Video Intelligence at Comcast29:10- 34:05  Building Elysia.ai Labs34:06- 39:59 Generative AI and Search40:00- 49:26  Challenges of Solo Entrepreneurship49:27- 53:03 Client Interaction and Preparedness53:04- 57:35  Bridging the Digital Divide57:36 1:04:34 Building Collaborative Communities1:04:35 -1:08:01 AI Agents in Business1:08:02- 1:13:56 AI's Impact on Workplaces1:13:57- 1:18:38 Ethical and Responsible Use of AI1:18:38 - 1:20:46 ClosureUseful Links and Resourceshttps://uk.linkedin.com/in/eschwaahttps://aibusiness.com/author/erik-schwartzAbout citiesabc.comhttps://www.citiesabc.com/​​​​​​​​​​​ About businessabc.nethttps://www.businessabc.net/About fashionabc.orghttps://www.fashionabc.org/ About Dinis Guardahttps://www.dinisguarda.com/https://businessabc.net/wiki/dinis-guardaBusiness Inquiries- info@ztudium.comSupport the show

While your ketamine therapy practice may be transformative for individual patients, it represents only one piece of a larger healing puzzle. When mental health conditions appear ubiquitously across a culture, it signals systemic-level problems that require community-based solutions alongside your individual treatment approach.In this conversation, Sam Ko interviews Mike Margolies, co-founder of the Global Psychedelic Society and a decade-long veteran of psychedelic community building. Mike shares insights about moving beyond the medical model's individual focus to create healing communities that address root causes of widespread trauma, depression, and addiction.This discussion challenges you as a ketamine provider to think beyond individual patient care toward fostering therapeutic communities that support long-term healing and societal transformation.What You'll Learn in This Episode• Why widespread mental health conditions require community-level healing approaches, not just individual treatment• The ethical responsibility that comes with facilitating consciousness-altering experiences and why personal experience matters• Practical frameworks for building healing communities around your ketamine practice using existing psychedelic societiesEpisode 36 show notes:00:00 Teaser - The Experience as The Medicine00:44 Welcome to the Ketamine Startup Podcast01:51 Interview with Mike Margolies: Community Healing03:05 The Importance of Community in Psychedelic Therapy04:58 The Bio-Psychosocial Model of Medicine07:44 Integral Theory and Holistic Healing09:37 The Global Psychedelic Society: Origins and Evolution16:01 The Psychedelic Renaissance: Conferences and Trends19:56 Challenges and Ethical Considerations in Psychedelic Therapy28:32 The Rise of Ketamine Clinics31:27 Ethical Considerations in Ketamine Clinics32:19 Philosophy and Responsible Use of Ketamine34:52 Integration and Therapy Approaches37:33 Building a Psychedelic Community39:53 Vision for a Post-Prohibition World47:35 Advice for Aspiring Ketamine Clinic Owners50:40 Fun and Personal Insights56:06 Conclusion and Contact InformationThanks for listeningConnect with Mike at:Mike's website Mike's InstagramGlobal Psychedelic Society

Welcome to RIMScast. Your host is Justin Smulison, Business Content Manager at RIMS, the Risk and Insurance Management Society.   Justin interviews three RISKWORLD attendees at RISKWORLD 2025. They are first, Audrey Trim of Thomson Rivers University, second, Lucy Straker of Beazley, and third, François Beaume of Sonepar and AMRAE.   Audrey Trim shares information about her career and her experiences at RISKWORLD and on the Board at BC RIMS. She introduces the Second Annual Coast to Coast Risk Management Legacy Challenge for Canada and tells how student teams can compete.   Lucy Straker describes the growing risk of political violence and active assailant events, and what insurance products are needed on top of general liability. She offers strategies for preventing and mitigating violent events.   François Beaume presents the 17th Annual AMRAE RMIS Panorama, a survey of vendors and risk managers, with insights into the software and technology available to corporate risk teams. The Panorama and data sets are freely available online in French and English at the link below. Listen in for a glimpse of the variety of education at RISKWORLD. Be sure to save the dates May 3rd through the 6th for RISKWORLD 2026 in Philadelphia.   Key Takeaways: [:01] About RIMS and RIMScast. [:16] About this episode of RIMScast, coming to you live from RISKWORLD 2025 in Chicago. There are so many topics and perspectives to cover! [:40] RIMS-CRMP Workshops! RIMS is co-hosting an intensive four-day program, which is your gateway to achieving two prestigious certifications, the DRI Certified Business Continuity Professional (CBCP) and the RIMS Certified Risk Management Professional (RIMS-CRMP). [:59] This workshop will be held from May 19th through the 22nd in collaboration with DRI International. Links to these courses can be found through the Certification page of RIMS.org and this episode's show notes. [1:14] Virtual Workshops! On June 12th, Pat Saporito will host “Managing Data for ERM”, and she will return on June 26th to present the very popular new course, “Generative AI for Risk Management”. [1:31] A link to the full schedule of virtual workshops can be found on the RIMS.org/education and RIMS.org/education/online-learning pages. A link is also in this episode's show notes. [1:42] We're at RISKWORLD this week, but preparations are already underway for the RIMS ERM Conference 2025 on November 17th and 18th in Seattle, Washington. RIMS is accepting educational session submissions through May 20th. [2:00] The best submissions will address current and future challenges facing ERM practitioners as well as provide leading practices and concrete takeaways for a diverse audience of risk professionals from industries or organizations of varied sizes, disciplines, functions, and roles. [2:16] These include officers, leaders, managers, and students. The link to the submission form is in this episode's show notes. [2:26] Of course, mark your calendars for November 17th and 18th, and I'll be sure to alert you when registration opens. [2:34] RISKWORLD 2025 was one of the highlights of the 75th Anniversary of RIMS. We had a fantastic time here at McCormick Place in Chicago. We've got a lot of perspectives that we're going to cover! [2:47] Our first guest is the Responsible Use of Space Coordinator in the Risk Management Department of Thomson Rivers University in British Columbia and a Board Member of BC RIMS. She is making her RISKWORLD and RIMScast debut. [3:04] Audrey Trim is here to tell us about her experience as a first-time attendee and the 2025 Coast-to-Coast Risk Management Legacy Challenge, which was a big draw among the students at RIMS Canada 2024, and we expect that to possibly outdo itself in 2025. [3:24] You could sense the energy on the exhibit room floor on Day 1 of RISKWORLD. Let's get to it! [3:32] Interviews! Audrey Trim, welcome to RIMScast! [3:38] On RISKWORLD Day 1, Audrey enjoyed the Matha Stewart opening keynote. It was a great, inspirational show. Audrey has taken in some great sessions. She's looking forward to some educational seminars. This is Audrey's first RISKWORLD; it will not be her last! [4:57] Audrey explains her job title, Responsible Use of Space Coordinator. She oversees the non-academic space, among other things, on the Thomson Rivers University campus. She focuses on the best use of the space in a responsible way. [6:07] In earlier roles, Audrey worked on the 2014 Tim Hortons Brier in Kamloops and was an Event Coordinator for the City of Kamloops. She also coordinated a Buskers Festival. Then she fell into risk management, and she's loving it. [6:28] Audrey joined the Risk Group at Thomson Rivers three years ago. She became a BC RIMS member and now serves on the chapter board. Audrey is on the organizing committee of the Coast to Coast Risk Management Legacy Challenge, working with the SA RIMS Chapter. [7:01] This is the Second Annual Coast to Coast Risk Management Legacy Challenge for Canada. They will try to outdo the premier year. The Challenge involves students in teams of four from universities across Canada. [7:31] The teams get a case study and compete for the top two spots. The top two teams will get a chance to present their findings at the 2025 RIMS Canada Conference, which will be in Calgary, Alberta, from September 14th through 17th. [7:50] This year, Ken Letander, Case Study Champion, owner and Founder of Strat First Inc., a Canadian risk management firm, has chosen the case study topic: Reporting, Set Aside, Spend: Indigenous business joint venture, ethical dilemmas, and program integrity benefits. [8:15] It's going to be a big draw. Audrey hopes lots of teams apply. Ken Letander and others will judge the entries. [8:45] Audrey describes the passion and thought that went into the submissions to the 2024 Coast to Coast Challenge. The winning submission developed a tool to measure health equity across the province. The tool was given to the Fraser Health Authority to use day-to-day.  [9:35] The Coast to Coast Challenge is open to students across Canada. One of the members of the winning team last year changed her direction from business to risk management, because she had such a great experience at the conference and during the case study. [10:38] Apply to join the Coast to Coast Risk Management Legacy Challenge by May 24th. The case study will be assigned on May 30th. Each team submits a 10-page report. The judges will pick the top two teams to present at the RIMS Canada Conference 2025. [10:55] A link to the submissions page and contact information is in this episode's show notes. [11:16] Audrey's advice to anyone considering attending RISKWORLD 2026: “Know where you're going and how to get around the conference. Also, curate your sessions. There are a lot of options here. Pick out the ones that will have an impact on you and teach you something great.” [11:35] “There are so many networking opportunities. Take advantage of those. Get out there. Don't be afraid to try new things!” [11:39] RIMS Canada 2025 will be held from September 14th through 17th in Calgary. Registration will open soon. Audrey says, “Do it! The RIMS Canada Conference was a great opportunity to meet people and network!” [12:20] Plug Time! RIMS Webinars! We are back on May 22nd, with GRC, a TÜV SÜD Company, and their newest session, “Asset Valuations in 2025: Managing Tariffs, Inflation, and Rising Insurance Scrutiny”. [12:36] On June 5th, Zywave joins us to discuss “Today's Escalating Risk Trajectory: What's the Cause and What's the Solution?” [12:47] On June 17th, Origami Risk returns to present “Strategic Risk Financing in an Unstable Economy: Leveraging Technology for Efficiency and Cost Reduction”. This session was rescheduled from May. If you were already registered, you do not need to take any action. [13:03] More webinars will be announced soon and added to the RIMS.org/Webinars page. Go there to register. Registration is complimentary for RIMS members. [13:15] Spencer Educational Foundation's Grants program is starting soon. Spencer's goal to help build a talent pipeline of risk management and insurance professionals is achieved, in part, by its collaboration with risk management and insurance educators across the U.S. and Canada. [13:34] Since 2010, Spencer has awarded over $3.3 million in General Grants to support over 130 student-centered experiential learning initiatives at universities and RMI non-profits. Spencer's 2026 application process is now open through July 30th, 2025. [13:55] General Grant awardees are typically notified at the end of October. Learn more about Spencer's General Grants through the Programs tab of SpencerEd.org. [14:05] On the 7th of October, the New Jersey RIMS Chapter will return to the beautiful Fiddler's Elbow Country Club in Bedminster, New Jersey, for their Annual Charity Golf/Pickleball Event. [14:18] Registration is open, and the event proceeds are used to fund the chapter's Spencer and Kids' Chance Scholarships. It was the filming location for the upcoming movie sequel, Happy Gilmore 2. For more information and to register, please NewJersey.RIMS.org. [14:42] My next guest was a panelist on several RIMS webinars. I was delighted to see her, so we could record this special segment live at RISKWORLD 2025. She is Lucy Straker. She is the focus group leader for U.S. Political Violence & Deadly Weapons Protection at Beazley. [15:00] We will talk about the trends she's seeing in her area of practice. [15:06] Lucy Straker, welcome to RIMScast!  [15:29] In 2016, Beazley looked at the landscape as it relates to terrorism and active assailant events and realized that traditional insurance options weren't providing sufficient solutions for its clients. Beazley created a product and a marketplace around active armed assailant events. [16:02] Lucy says what you see in the media is a fraction of what's happening. The media report the biggest and worst events. The risk is far higher than what is reported in the media. [16:31] Violence and shootings have increased. People are now more aware of the risk and are trying to respond to it through insurance products and legislation such as California's SB-553, with much more focus on preventing these events from occurring. [16:54] We want to avoid workplace violence before it becomes something. A lot of clients think they already have coverage for workplace violence in their traditional general liability insurance. [17:19] Recently, general liability carriers have put exclusions on their products for AMB, firearms, weapons, or the expected or intended injury exclusion found in a traditional ISA form. [17:38] Lucy says clients need to be aware that there is a potential coverage gap. A misconception among clients is that none of them think they will have a shooting. They're in denial. When there's a shooting, you hear, “I never thought it would happen to me!” [18:03] We're at a stage where gun violence is so prevalent in the U.S. that you can't argue you didn't think something was going to happen. You have to plan and prepare for the worst-case scenario. [18:28] Lucy advises risk leaders to buy coverage to help them cover the gap. They do not have to be alone. With most shootings, there is a warning sign. There is a trail. There are things to do to prevent it. [18:52] As a company, protocols have to be embedded from top-down and bottom-up. The company has to communicate every plan and procedure to its employees. Employees have to be trained and retrained. This is not something they're going to be thinking about every day. [19:09] You have to engage with your security team. You have to screen people. You have to screen the company. You have to create a culture of reporting. People are not going to report something unless they feel comfortable reporting it. You need to have anonymous reporting. [19:24] You need to instill a culture in your company of “See something, say something, report it.” It could be someone coming in and acting funny, or someone posting on social media, “I'm going to go carry out a shooting.” [19:46] More often than not, if someone's going down a path to violence, there are signs. They don't just wake up one morning and say they're going to go carry out a shooting. There are warning signs, and we want to catch them before it becomes something more material. [20:13] There are different lines of coverage and ways that coverage can respond, such as active assailant forms. Think about your business and other areas of your business you might not have thought about. Lucy mentions the United Health Care CEO being shot off the premises. [20:38] It was a targeted event. Were there warning signs online by Luigi, the perpetrator? How can you identify those threats? Make sure you have risk management and preventive measures in place. Think of the litigious landscape. We're now seeing more nuclear verdicts. [21:02] People always want someone to blame. You've got to make sure that, if something happens, you're doing right by the people to try and eliminate and reduce that liability on the back end. [21:15] RIMS Plug! The first of hopefully many RIMS Texas Regional Conferences will be held in San Antonio from August 4th through the 6th, 2025. This groundbreaking event is set to unite the Texas RIMS Chapters and welcome risk management professionals from around the world. [21:35] Guess what, folks! Registration is now open! The advance rate is available through May 16th. A link is in this episode's show notes. You can also visit the Events page of RIMS.org to register. We look forward to seeing you in Texas! [21:51] Let's Move to My Final Guest, François Beaume, The SVP for Risks and Insurance at Sonepar and the VP of AMRAE (The Association for Corporate Risk and Insurance Management)! [22:16] François Beaume is here to discuss the findings of the 17th Edition of the RMIS Panorama that AMRAE produces in association with and with the support of several groups, including RIMS. [22:36] François Beaume, welcome back to RIMScast! [23:02] AMRAE has the 17th Annual Edition of the RMIS Panorama available. In 17 years, the most significant evolution in risk management information system offerings has been the integration of advanced technologies like AI, automation, and data visualization. [23:57] These add-ons transform the software from a pure data management tool to a much more sophisticated platform that provides productive analyses and real-time risk monitoring to enhance decision-making capabilities and processes in a wider scope of topics. [24:40] Panorama is a collection of surveys. One survey focuses on vendors and one survey focuses on risk managers. François says there is still room for improvement in this solution. Progress has been made on flexibility and integration capability, with changes to come. [25:12] François sees a need to guarantee the success of such solutions, train users, and provide support to users to streamline how they use the system. Vendors receive feedback to provide customizable solutions, enhanced integration capability, training, user clubs, and more. [26:07] Interconnection is a key area of these tools. With APIs, modular architecture, and code-based solutions, more and more, these tools can connect with other risk management information systems. Some corporations have several risk management systems. [26:45] There are more and more interconnected features in these systems, to allow the risk manager and all the teams involved in the use of the risk management programatics to extract the most important benefits from the use of the tool. [27:04] ESG is a key area where this matters more and more. In Europe, there is a strong push for ESG compliance that requires corporations to gather and manage a huge volume of data that, when organized, is helpful to fuel the risk management processes. [27:33] The report evaluates 52 solutions in four functional categories, covering 17 functional modules and 14 technical modules to allow you to compare and assess the value of the solutions and if they are compatible with your company's technology for audit, risk, and more. [28:22] AMRAE is looking at the functional scope and the depth of the features that are offered. Is the scope well-covered? They are looking at technical capabilities; is it easy to integrate a solution? Is it scalable? How is the user interface? What can the admin customize? [28:45] AMRAE also gathers user feedback and testimonials from using a given tool in real life. That feedback provides robust data capabilities, seamless integration capabilities, and more user-friendly interfaces that will benefit the users of the tool. [29:36] RMIS vendors use AI in predictive analytics of historical data. Risk management is gathering and dealing with historical data linked to risk management topics to anticipate future risks. [29:59] Vendors use AI to automate workflows and streamline data from the field and validation from the stakeholders, reducing manual intervention and increasing confidence in the data quality. All data will be analyzed more easily with AI and integrated into interactive dashboards. [30:34] Dashboarding has improved over the past year to provide more interactive dashboards for better risk insights and risk decision-making processes. [31:10] François has advice for risk managers looking for RMIS software. His most valuable advice is to use the RMIS Panorama. It's freely available to anyone. You can get it in French or English. Besides the Panorama PDF, there is an online platform that allows customization. [31:48] The entire data set from the vendor and risk manager surveys is freely available online. You can customize your analytics of the data based on your use case. [32:32] François speaks of captives and the evolving reinsurance market. The market today is favorable toward captives, a powerful tool for improving corporate risk management and the way corporations are living with ESG. There is a strong push in Europe for captives. [33:22] François has seen the creation of about 20 captives in France. Corporations need captives in the risk management process and risk financing optimization. [34:00] Special thanks again to all of our guests and all of the RISKWORLD attendees who made this year's RISKWORLD Conference so very special. Links to RISKWORLD coverage are in this episode's show notes. [34:13] Mark your calendars for May 3rd through the 6th, and join us at RISKWORLD 2026 in Philadelphia. [34:20] Plug Time! You can sponsor a RIMScast episode for this, our weekly show, or a dedicated episode. Links to sponsored episodes are in the show notes. [34:49] RIMScast has a global audience of risk and insurance professionals, legal professionals, students, business leaders, C-Suite executives, and more. Let's collaborate and help you reach them! Contact pd@rims.org for more information. [35:06] Become a RIMS member and get access to the tools, thought leadership, and network you need to succeed. Visit RIMS.org/membership or email membershipdept@RIMS.org for more information. [35:24] Risk Knowledge is the RIMS searchable content library that provides relevant information for today's risk professionals. Materials include RIMS executive reports, survey findings, contributed articles, industry research, benchmarking data, and more. [35:40] For the best reporting on the profession of risk management, read Risk Management Magazine at RMMagazine.com. It is written and published by the best minds in risk management. [35:54] Justin Smulison is the Business Content Manager at RIMS. You can email Justin at Content@RIMS.org. [36:01] Thank you all for your continued support and engagement on social media channels! We appreciate all your kind words. Listen every week! Stay safe!   Links: RIMS Texas Regional 2025 — August 3‒5 | Advance registration rates now open. ERM Conference 2025 — Call for Submissions (Through May 20) RIMS-Certified Risk Management Professional (RIMS-CRMP) RISK PAC | RIMS Advocacy RIMS Risk Management magazine RIMS Now The Strategic and Enterprise Risk Center Spencer Educational Foundation — General Grants 2026 — Application Dates RISKWORLD 2025 — Show Daily! [Bottom of page] 2025 Coast-To-Coast Risk Management Challenge — Applications Open Through May 23 AMRAE RMIS Panorama 2025 New Jersey RIMS Spencer Golf/Pickleball Outing — Oct. 7 Global Trio of Risk Leaders Inducted Into RIMS Risk Management Hall of Fame RIMS Webinars: RIMS.org/Webinars “Asset Valuations in 2025: Managing Tariffs, Inflation, and Rising Insurance Scrutiny” | Sponsored by GRC, a TÜV SÜD Company | May 22, 2025 “Today's Escalating Risk Trajectory: What's the Cause & What's the Solution?” | Sponsored by Zywave | June 5, 2025 “Strategic Risk Financing in an Unstable Economy: Leveraging Technology for Efficiency and Cost Reduction” | Sponsored by Origami Risk | June 17, 2025   Upcoming RIMS-CRMP Prep Virtual Workshops: CBCP & RIMS-CRMP Exam Prep Virtual Bootcamp: “Mastering Business Continuity & Risk Management” | May 19‒22, 2025 | In Collaboration with DRI International Full RIMS-CRMP Prep Course Schedule “Managing Data for ERM” | June 12 | Instructor: Pat Saporito  “Generative AI for Risk Management” | June 26 | Instructor: Pat Saporito See the full calendar of RIMS Virtual Workshops RIMS-CRMP Prep Workshops   Related RIMScast Episodes: “RIMS 2025 Risk Manager of the Year, Jennifer Pack” “Risk and Leadership Patterns with Super Bowl Champion Ryan Harris” (RISKWORLD 2025 Keynote) “(Re)Humanizing Leadership in Risk Management with Holly Ransom” “Risk and Relatability with Rachel DeAlto” “Live From RISKWORLD 2024!” “The Rise of RMIS with AMRAE's VP, François Beaume” (2019)   Sponsored RIMScast Episodes: “The New Reality of Risk Engineering: From Code Compliance to Resilience” | Sponsored by AXA XL (New!) “Change Management: AI's Role in Loss Control and Property Insurance” | Sponsored by Global Risk Consultants, a TÜV SÜD Company “Demystifying Multinational Fronting Insurance Programs” | Sponsored by Zurich “Understanding Third-Party Litigation Funding” | Sponsored by Zurich “What Risk Managers Can Learn From School Shootings” | Sponsored by Merrill Herzog “Simplifying the Challenges of OSHA Recordkeeping” | Sponsored by Medcor “Risk Management in a Changing World: A Deep Dive into AXA's 2024 Future Risks Report” | Sponsored by AXA XL “How Insurance Builds Resilience Against An Active Assailant Attack” | Sponsored by Merrill Herzog “Third-Party and Cyber Risk Management Tips” | Sponsored by Alliant “RMIS Innovation with Archer” | Sponsored by Archer “Navigating Commercial Property Risks with Captives” | Sponsored by Zurich “Breaking Down Silos: AXA XL's New Approach to Casualty Insurance” | Sponsored by AXA XL “Weathering Today's Property Claims Management Challenges” | Sponsored by AXA XL “Storm Prep 2024: The Growing Impact of Convective Storms and Hail” | Sponsored by Global Risk Consultants, a TÜV SÜD Company “Partnering Against Cyberrisk” | Sponsored by AXA XL “Harnessing the Power of Data and Analytics for Effective Risk Management” | Sponsored by Marsh “Accident Prevention — The Winning Formula For Construction and Insurance” | Sponsored by Otoos “Platinum Protection: Underwriting and Risk Engineering's Role in Protecting Commercial Properties” | Sponsored by AXA XL “Elevating RMIS — The Archer Way” | Sponsored by Archer   RIMS Publications, Content, and Links: RIMS Membership — Whether you are a new member or need to transition, be a part of the global risk management community! RIMS Virtual Workshops On-Demand Webinars RIMS-Certified Risk Management Professional (RIMS-CRMP) RISK PAC | RIMS Advocacy RIMS Strategic & Enterprise Risk Center RIMS-CRMP Stories — Featuring RIMS President Kristen Peed!   RIMS Events, Education, and Services: RIMS Risk Maturity Model®   Sponsor RIMScast: Contact sales@rims.org or pd@rims.org for more information.   Want to Learn More? Keep up with the podcast on RIMS.org, and listen on Spotify and Apple Podcasts.   Have a question or suggestion? Email: Content@rims.org.   Join the Conversation! Follow @RIMSorg on Facebook, Twitter, and LinkedIn.   About our guests: Audrey Trim, BTM, Responsible Use of Space Coordinator, Risk Management, Risk and Safety Services, Thomson Rivers University BC RIMS Board Member   Lucy Straker, Focus Group Leader U.S. Political Violence & Deadly Weapons Protection, Beazley   François Beaume, SVP Risks and Insurance, Sonepar, VP AMRAE, [Association for Corporate Risk and Insurance Management]   Production and engineering provided by Podfly.  

In this episode of the DD214 Network podcast, special guest Jeremy Strobridge joins the conversation to explore everything from humorous food and road trip stories to serious takes on content creation challenges and internet privacy. Topics include the legality of marijuana and firearm ownership, responsible gun use, emergency preparedness, aging, and reflections on 420. Wrestling fans will enjoy deep dives into WrestleMania highlights, wrestling merchandise nostalgia, and the evolution of fan experiences. The episode wraps with thoughts on superhero movies, mental health awareness, and celebrating personal milestones.Chapters00:00 Introduction to DD214 Network Podcast05:17 The Impact of the Internet on Privacy09:31 Nostalgia and Past Podcast Episodes15:14 Responsible Use of Firearms and Alcohol21:14 Fist Fights and Brotherhood: The Bonds of Friendship25:33 Lessons from the Bar: Stab Wounds and Responsibility29:32 Ammo and Supply Chain Insights33:33 Aging and Personal Reflections38:12 Quirky Films and Nostalgia40:44 Launching the B Lid Shop42:13 WrestleMania Highlights and Predictions44:56 Wrestling Injuries and Performances48:17 WWE Acquires AAA Wrestling51:42 The Evolution of Wrestling Knowledge53:37 WrestleMania Stage and Crowd Dynamics54:25 Sound Quality and Audience Experience56:05 WrestleMania 40: A Comparison of Years57:03 Main Event Analysis: Double Turns and Storylines01:00:03 Iconic WrestleMania Moments01:02:50 Nostalgia in Wrestling and Merchandise01:05:12 Favorite Championship Belts and Their Significance01:09:29 The Evolution of Wrestling Merchandise01:12:46 The Quirky Side of Wrestling Collectibles01:13:15 Pop Culture and Nostalgia in Modern Media01:16:31 Anticipation for Upcoming Superhero Movies01:19:14 The Future of Comic Book Adaptations01:22:04 The Return of the Punisher01:25:22 Casting and Character Development in Marvel01:29:14 Responsibility and Awareness During Celebrations01:32:51 The Importance of Mental Health Awareness01:34:00 Celebrating Life's Milestones01:35:47 Final Thoughts and GoodbyesDD214 Network PodcastDirected & Produced by Jonathan ‘Clean' SanchezHosted by Joe Squillini & Jay CampbellEdited by Clean Sanchez Media, LLCMusic by Shrieks666 ("Shadow Surfing," "Voices Getting Louder") – Check them out on Bandcamp!Website: CleanSanchezMedia.comDisclaimer: This Podcast contains adult language. Adult Supervision is advised.Fair Use Disclaimer:The content provided on this podcast may include material subject to copyright protection. In accordance with the principles of "fair use" as defined in Section 107 of the Copyright Act of 1976, the use of copyrighted material on this podcast is for purposes such as criticism, comment, news reporting, teaching, scholarship, or research.The determination of whether the use of copyrighted material constitutes fair use is made on a case-by-case basis, taking into account various factors outlined in Section 107. The inclusion of such material is not an endorsement by the DD214 Network Podcast or Clean Sanchez Media, LLC, but is meant to enrich and contribute to discussions within the specified purposes of fair use. All copyrights and trademarks are the property of their respective owners.Shop official merch for DD214 Network: http://www.CleanSanchezMedia.com

Christopher Lloyd is the secretary general of the Responsible Use of Medicines in Agriculture Alliance (RUMA) based in the United Kingdom. In this episode, he discusses the organization's role in promoting best practices across various livestock sectors, including salmon farming.

Send us a textAI and Technology in Veterinary Medicine: Insights from Dr. Jonathan LustgartenIn this episode of Vet Life Reimagined, returning guest Dr. Jonathan Lustgarten, Director of AI and Machine Learning at Mars Veterinary Health, discusses the rapid evolution of AI in veterinary medicine. Over the past two and a half years, AI tools have exploded within the field, impacting diagnostics, communication, and career opportunities for veterinary professionals. The conversation covers the burgeoning role of AI in veterinary informatics, the challenges of adopting new technologies, and the importance of education in responsibly integrating AI into veterinary practices. Dr. Lustgarten also touches on future trends, the role of AI in client communication, and how AI can offer new career pathways for veterinarians.Resources:Dr. Lustgarten's first appearance on Vet Life Reimagined (audio) (YouTube)This episode on YouTube00:00 Introduction and Guest Reintroduction00:38 AI Evolution in Veterinary Medicine01:31 Career Changes and AI Impact02:19 AI Tools and Their Adoption04:38 Understanding Veterinary Informatics07:31 Challenges and Opportunities with AI13:44 Future Trends and Education in Veterinary AI21:53 Legal Ramifications of AI in Veterinary Medicine22:08 AI in Automated Driving: Expectations vs. Reality23:12 AI's Role in Veterinary Education and Practice24:01 Client-Centric AI Innovations in Veterinary Medicine24:36 Wearable Technology and AI for Pets25:07 AI-Driven Client Communication Tools26:01 Challenges and Benefits of AI in Veterinary Medicine29:27 The Future of AI in Veterinary Medicine32:23 Data Management and AI: Current State and Future Prospects36:49 Responsible Use of AI and Data Privacy40:41 Career Pathways in Veterinary Medicine with AI42:45 Final Thoughts on AI and Technology in Veterinary MedicineSupport the showMore Vet Life Reimagined?

No one knows better than our clients what is going on in their world - their stressors, symptoms, triumphs, values, goals… but sometimes it can also be helpful to hear additional perspectives from others in our client's world. In this episode the P4P hosts discuss the potential relevance of collateral information in assessment, case conceptualization and treatment planning. We talk about how collateral information can sometimes enhance our understanding of our client's environment, behaviors, and experiences as well as some of the pitfalls to avoid when involving others in the therapeutic process. Listen in for some great examples of when collateral information saved the day AND when we experienced collateral conundrums. As always we leave you with actionable intel to help support how YOU use collaterals in your EBP work.Bios:Drs. Ermold, Holloway and Lefkowitz are clinical psychologists who provide training and consultation at the Center for Deployment Psychology. Their specialties include military psychology, the assessment and treatment of trauma (PE and CPT), sleep disorders and more. They are passionate about delivering EBP's effectively and creating a supportive community for providers to learn and grow in their EBP work.Calls-to-action:Always follow the laws and ethical guidelines of your state and disciplineRemember that the goal of gathering collateral information is to facilitate your client's treatment. Always clarify the goals of a consultation and remember to prioritize the therapeutic relationship.Utilize consultationSubscribe to the Practical for Your Practice PodcastSubscribe to The Center for Deployment Psychology Monthly Email - https://deploymentpsych.org/CDP-MED-Opt-InSend us your questions, comments, stories, and/or topic/guest suggestions! We'd love to hear from you!Practical for Your Practice voice mail: speakpipe.com/cdpp4pPractical for Your Practice email: cdp-podcast-ggg@usuhs.edu

Introducing Claudia Oshry: How to Stop Letting Your Body Image Hold You Back & Build Lasting Confidence from On Purpose with Jay Shetty.Follow the show: On Purpose with Jay ShettyDo you ever feel held back by body image? What’s one thing that instantly boosts your confidence? Today, Jay welcomes Claudia Oshry, a comedian, podcaster, and social media personality. Claudia is the co-host of the extremely popular podcast "The Toast" and has gained a large following on Instagram for her relatable and often self-deprecating posts. Claudia has been open about her personal life, including her struggles with body image and her journey to motherhood. Claudia opens up about the misconceptions surrounding her online persona, her journey with Ozempic, and her decision to embrace motherhood. She discusses the challenges of vulnerability on social media and the importance of self-acceptance and living life on your own terms and finding fulfillment. Jay and Claudia share their personal experiences with weight and body image, revealing the societal pressures and internal struggles they have faced. They explore the complexities of Claudia's weight loss journey and decide to use Ozempic openly in the public eye. Claudia shares her personal transformation and the newfound confidence she gained through her weight loss journey. In this interview, you'll learn: How to Overcome Misconceptions How to Embrace Vulnerability How to Deal with Weight Stigma How to Build Confidence How to Find the Right Partner Remember, it's okay to seek support and share your struggles. Embrace your true self, live life on your own terms, and never stop pursuing your dreams. With Love and Gratitude, Jay Shetty Join over 750,000 people to receive my most transformative wisdom directly in your inbox every single week with my free newsletter. Subscribe here. Join Jay for his first ever, On Purpose Live Tour! Tickets are on sale now. Hope to see you there! What We Discuss: 00:00 Intro 02:27 How It Feels to Be Misunderstood 04:57 Protect Your Own Peace 06:56 What is Fat Camp? 08:34 The Struggle of Losing Weight 12:38 Responsible Use of Ozempic 16:20 Struggle with Self Image and Confidence 19:36 How Does Getting Pregnant Feel? 24:18 Getting Ready to Start a Family 30:46 Friends Change Throughout Your Life 33:08 Choosing What to Share About Your Life 39:45 Becoming a Content Creator 42:45 Learnings from the Corporate Life 46:16 Building a Brand as a One-Man Team 49:26 Smart Advice for Content Creators 52:49 Just Get Started 55:08 Stability is Beneficial in Running a Business 58:04 Running a Business with Family 01:01:44 How to Record a Good Episode 01:03:27 Know When to Listen 01:07:11 The Worst Type of Humor 01:10:46 Greatest Lesson from Grief 01:14:50 The Girl with a Dead Dad 01:18:37 The Dangers of Exposing Children Online 01:21:30 Claudia on Final Five Episode Resources: Claudia Oshry | Website Claudia Oshry | TikTok Claudia Oshry | Instagram Claudia Oshry | Youtube Girl With No Job: The Crazy Beautiful Life of an Instagram Thirst MonsterSee omnystudio.com/listener for privacy information.DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Do you ever feel held back by body image? What’s one thing that instantly boosts your confidence? Today, Jay welcomes Claudia Oshry, a comedian, podcaster, and social media personality. Claudia is the co-host of the extremely popular podcast "The Toast" and has gained a large following on Instagram for her relatable and often self-deprecating posts. Claudia has been open about her personal life, including her struggles with body image and her journey to motherhood. Claudia opens up about the misconceptions surrounding her online persona, her journey with Ozempic, and her decision to embrace motherhood. She discusses the challenges of vulnerability on social media and the importance of self-acceptance and living life on your own terms and finding fulfillment. Jay and Claudia share their personal experiences with weight and body image, revealing the societal pressures and internal struggles they have faced. They explore the complexities of Claudia's weight loss journey and decide to use Ozempic openly in the public eye. Claudia shares her personal transformation and the newfound confidence she gained through her weight loss journey. In this interview, you'll learn: How to Overcome Misconceptions How to Embrace Vulnerability How to Deal with Weight Stigma How to Build Confidence How to Find the Right Partner Remember, it's okay to seek support and share your struggles. Embrace your true self, live life on your own terms, and never stop pursuing your dreams. With Love and Gratitude, Jay Shetty Join over 750,000 people to receive my most transformative wisdom directly in your inbox every single week with my free newsletter. Subscribe here. Join Jay for his first ever, On Purpose Live Tour! Tickets are on sale now. Hope to see you there! What We Discuss: 00:00 Intro 02:27 How It Feels to Be Misunderstood 04:57 Protect Your Own Peace 06:56 What is Fat Camp? 08:34 The Struggle of Losing Weight 12:38 Responsible Use of Ozempic 16:20 Struggle with Self Image and Confidence 19:36 How Does Getting Pregnant Feel? 24:18 Getting Ready to Start a Family 30:46 Friends Change Throughout Your Life 33:08 Choosing What to Share About Your Life 39:45 Becoming a Content Creator 42:45 Learnings from the Corporate Life 46:16 Building a Brand as a One-Man Team 49:26 Smart Advice for Content Creators 52:49 Just Get Started 55:08 Stability is Beneficial in Running a Business 58:04 Running a Business with Family 01:01:44 How to Record a Good Episode 01:03:27 Know When to Listen 01:07:11 The Worst Type of Humor 01:10:46 Greatest Lesson from Grief 01:14:50 The Girl with a Dead Dad 01:18:37 The Dangers of Exposing Children Online 01:21:30 Claudia on Final Five Episode Resources: Claudia Oshry | Website Claudia Oshry | TikTok Claudia Oshry | Instagram Claudia Oshry | Youtube Girl With No Job: The Crazy Beautiful Life of an Instagram Thirst MonsterSee omnystudio.com/listener for privacy information.

Introducing Claudia Oshry: How to Stop Letting Your Body Image Hold You Back & Build Lasting Confidence from On Purpose with Jay Shetty.Follow the show: On Purpose with Jay ShettyDo you ever feel held back by body image? What’s one thing that instantly boosts your confidence? Today, Jay welcomes Claudia Oshry, a comedian, podcaster, and social media personality. Claudia is the co-host of the extremely popular podcast "The Toast" and has gained a large following on Instagram for her relatable and often self-deprecating posts. Claudia has been open about her personal life, including her struggles with body image and her journey to motherhood. Claudia opens up about the misconceptions surrounding her online persona, her journey with Ozempic, and her decision to embrace motherhood. She discusses the challenges of vulnerability on social media and the importance of self-acceptance and living life on your own terms and finding fulfillment. Jay and Claudia share their personal experiences with weight and body image, revealing the societal pressures and internal struggles they have faced. They explore the complexities of Claudia's weight loss journey and decide to use Ozempic openly in the public eye. Claudia shares her personal transformation and the newfound confidence she gained through her weight loss journey. In this interview, you'll learn: How to Overcome Misconceptions How to Embrace Vulnerability How to Deal with Weight Stigma How to Build Confidence How to Find the Right Partner Remember, it's okay to seek support and share your struggles. Embrace your true self, live life on your own terms, and never stop pursuing your dreams. With Love and Gratitude, Jay Shetty Join over 750,000 people to receive my most transformative wisdom directly in your inbox every single week with my free newsletter. Subscribe here. Join Jay for his first ever, On Purpose Live Tour! Tickets are on sale now. Hope to see you there! What We Discuss: 00:00 Intro 02:27 How It Feels to Be Misunderstood 04:57 Protect Your Own Peace 06:56 What is Fat Camp? 08:34 The Struggle of Losing Weight 12:38 Responsible Use of Ozempic 16:20 Struggle with Self Image and Confidence 19:36 How Does Getting Pregnant Feel? 24:18 Getting Ready to Start a Family 30:46 Friends Change Throughout Your Life 33:08 Choosing What to Share About Your Life 39:45 Becoming a Content Creator 42:45 Learnings from the Corporate Life 46:16 Building a Brand as a One-Man Team 49:26 Smart Advice for Content Creators 52:49 Just Get Started 55:08 Stability is Beneficial in Running a Business 58:04 Running a Business with Family 01:01:44 How to Record a Good Episode 01:03:27 Know When to Listen 01:07:11 The Worst Type of Humor 01:10:46 Greatest Lesson from Grief 01:14:50 The Girl with a Dead Dad 01:18:37 The Dangers of Exposing Children Online 01:21:30 Claudia on Final Five Episode Resources: Claudia Oshry | Website Claudia Oshry | TikTok Claudia Oshry | Instagram Claudia Oshry | Youtube Girl With No Job: The Crazy Beautiful Life of an Instagram Thirst MonsterSee omnystudio.com/listener for privacy information.DISCLAIMER: Please note, this is an independent podcast episode not affiliated with, endorsed by, or produced in conjunction with the host podcast feed or any of its media entities. The views and opinions expressed in this episode are solely those of the creators and guests. For any concerns, please reach out to team@podroll.fm.

Lantz and Sam shared personal experiences, including Sam's upbringing as a missionary kid in Morocco and his experiences as a third culture kid. They also discussed the integration of their faith into their business lives, with Sam emphasizing the importance of loving and serving people in both contexts. Lastly, they discussed the evolution of their company, Snap Bar, and the use of AI tools in their work and personal lives, with a focus on responsible use. Snapbar creates highly engaging AI-powered photo & video experiences. Increase your event engagement and brand awareness with shareable, user-generated content that gets people talking! Sam Eitzen on LinkedIn -- Grow Your Business without Losing Heart Scan the health of your leadership and your business with a free assessment. www.lantzhoward.com

Explore the best moments from Vibe Science: Volume 1! In this episode, hosts Ryan Alford and Chris Hansen lead engaging conversations on wellness, longevity, and emotional health. Here's what to expect:Self-Care for Fulfillment: Ryan emphasizes the critical role of self-care in achieving a meaningful and balanced life.Balancing Success and Health: Chris shares strategies for maintaining personal health while pursuing financial success.Exploring Microdosing: Insights on how microdosing psychedelics can support emotional well-being and creativity.Nutritional Wisdom: Discussions on addressing deficiencies and embracing the simplicity of whole foods for optimal health.Destigmatizing Substances: An honest take on the stigmatization of certain drugs, advocating for decriminalization and responsible use.Personal Transformation: Inspiring stories that highlight the power of mindset, spirituality, and holistic wellness.Join us as we unpack innovative ideas and practical tips to elevate your well-being. Don't miss this journey toward a healthier, more fulfilling life! Follow us on Instagram: @Vibe.Science Subscribe to our YouTube Page: www.youtube.com/@Vibe.Science

In this episode of the Becker's Healthcare Podcast, Erika Spicer Mason hosts a dynamic conversation on the evolving role of healthcare data. Joined by Kathryn Spates, JD, ACNP-BC, of The Joint Commission and Jodi Daniel, JD, MPH, of Crowell Health Solutions, they explore the secondary uses of healthcare data, the importance of responsible practices, and The Joint Commission's groundbreaking Responsible Use of Health Data™ Certification. You can learn more about the Responsible Use of Health Data Certification here.This episode is sponsored by The Joint Commission.

In this episode of the Becker's Healthcare Podcast, Erika Spicer Mason hosts a dynamic conversation on the evolving role of healthcare data. Joined by Kathryn Spates, JD, ACNP-BC, of The Joint Commission and Jodi Daniel, JD, MPH, of Crowell Health Solutions, they explore the secondary uses of healthcare data, the importance of responsible practices, and The Joint Commission's groundbreaking Responsible Use of Health Data™ Certification. You can learn more about the Responsible Use of Health Data Certification here.This episode is sponsored by The Joint Commission.

NOTEBOOK LM HAS TAKEN CONTROL OF THE TRENDING COMMUNICATOR. EVERYTHING THAT FOLLOWS IS AI-GENERATED. Are you ready to supercharge your communication skills for the AI-driven future? Discover how to harness the power of artificial intelligence while keeping your human touch in this eye-opening episode of The Trending Communicator. In this captivating discussion, hosts Maichael AI and Laila AI take over the podcast to unpack the seismic shifts reshaping the world of communications. From the evolving nature of job descriptions to the rise of personal branding in an era of deepfakes, they cover the essential skills and strategies you need to thrive in this rapidly changing landscape. Listen as our hosts break down the PESO model (Paid, Earned, Shared, and Owned media) and explain how AI is blurring the lines between these traditional categories. You'll gain insights into how artificial intelligence can enhance your storytelling abilities, help you tailor messages for different audiences, and even serve as a data-driven coach for your communication efforts. But it's not all about technology. Maichael and Laila emphasize the critical importance of human skills like empathy, creativity, and ethical decision-making. They introduce the concept of "T-shaped" professionals - those who combine deep expertise in one area with a broad understanding of related fields - and explain why this versatility is crucial for success in modern communications teams. Throughout the episode, you'll find practical advice on: Building a personal brand that stands out in the age of AI Leveraging artificial intelligence as a powerful tool without losing your human touch Developing "forensic listening" skills to cut through information overload Creating adaptable, collaborative, and data-driven teams Embracing lifelong learning to stay ahead of the curve Whether you're a seasoned communications professional or just starting your career, this episode offers valuable insights into the future of the field. Don't miss this opportunity to prepare yourself for the exciting challenges and opportunities that lie ahead in the world of AI-enhanced communications. Listen in and hear about... Shifting job descriptions in the evolving communication landscape Leveraging AI as a tool to enhance human creativity and efficiency Building a strong personal brand through authenticity and storytelling Embracing continuous learning to stay ahead in a rapidly changing field Honing forensic listening skills to navigate information overload Integrating the PESO model for a well-rounded communication strategy Developing "T-shaped" skills to thrive in future communication roles Notable Quotes On Job Descriptions: "It's less about checking boxes and more about being adaptable and always learning." - LAILA AI [0:39 - 0:44] On Personal Branding: "Start with authenticity. Be real. Share your story." - LAILA AI [1:47 - 1:50] On Community: "Like a network of advisors, cheerleaders." - MAICHAEL AI [2:26 - 2:29] On AI in Communication: "It definitely is, but it's not about robots taking over. It's about using AI to make us better, more efficient." - LAILA AI [2:41 - 2:48] On AI as a Tool: "So it's a tool we can use to our advantage." - MAICHAEL AI [2:48 - 2:50]  Timestamped key moments from this episode (as generated by Fireflies.ai)

In a world where corporate ethics are often tested, the latest episode of the "Do Good to Lead Well" podcast brings a timely discussion with Ann Skeet, the Senior Director of the Markkula Center for Applied Ethics. This episode offers listeners a comprehensive exploration into the intricacies of leading with integrity amidst the challenges of today's corporate landscape. During our conversation, Ann discusses the need for a comprehensive approach to ethics education and highlights the need for systemic assessments rather than attributing misconduct to a single "bad apple." We also explore how systemic pressures can foster a culture of fear and ethics washing and why organizations must effectively address toxic high performers. The episode further explores the role of empathy in ethical leadership, underscoring its influence on decision-making and organizational dynamics. Practical applications of empathy, such as rotating assignments and fostering narrative integration through leadership stories, are discussed. In a time when businesses must navigate partisanship, self-regulate, and address pressing issues like climate change and DEI initiatives, ethical leadership is more critical than ever. This episode inspires listeners to embrace their potential as ethical leaders, regardless of their role or setting.  What You'll Learn: • How to foster a culture of trust and accountability within organizations. • The importance of empathy and ethics in decision-making and organizational dynamics. • Strategies for handling toxic high performers and conducting culture self-assessments. • How leaders can responsibly harness technology in the age of AI and disruptive innovations. Podcast Timestamps: (00:00) - An Introduction to Ethical Leadership (15:41) - Organizational Ethics and Risk Assessment (22:40) - Characteristics of Ethical Leadership (36:02) - Building Ethical Cultures Through Empathy (43:54) - Navigating Ethics in Technological Advancements (53:52) - Ethical Leadership in the Future More of Ann Skeet: Ann Skeet is the Senior Director of Leadership Ethics at the Markkula Center for Applied Ethics at Santa Clara University. Her work centers on the ethical challenges faced by leaders and their teams, with a focus on fostering healthy corporate cultures, ethical leadership practices, and governance frameworks that promote human flourishing. Ann teaches ethics literacy for boards through the Silicon Valley Executive Education Center at the Levy School of Business. She has played a pivotal role in global initiatives, including serving on the Steering Committee for the Responsible Use of Technology at the World Economic Forum and contributing to the Partnership on AI's Working Group on AI, Labor, and the Economy, co-authoring a framework for workforce well-being in AI-integrated workplaces. Additionally, Ann has co-authored Ethics in the Age of Disruptive Technologies: An Operational Roadmap and Voting for Ethics, a guide for evaluating candidates from an ethical perspective during elections. LinkedIn: https://www.linkedin.com/in/ann-gregg-skeet-239306/  Key Topics Discussed: Positive Leadership, Ethical Leadership, Corporate Culture, Organizational Ethics, Risk Assessment, Silicon Valley, Sarbanes-Oxley, Integrity, Systemic Issues, Misconduct, Ethics Education, Toxic High Performers, Empathy, Applied Ethics, Ethical Decision-Making, Code of Conduct, Ethics Training, Artificial Intelligence, Technological Advancements, Responsible Technology, Governance Framework, Continuous Improvement, Public Trust, Polarized Political Landscape, CEO Success More of Do Good to Lead Well: Website: https://craigdowden.com/LinkedIn: https://www.linkedin.com/in/craigdowden/

Building on part one of the Responsible Use series, Tessa Burg and Patty Parobek explore how organizations can assess AI tools, minimize risks and scale AI-driven innovations effectively.  They share a framework—covering everything from understanding data privacy and compliance to evaluating ROI—designed to empower businesses to adopt AI responsibly while driving measurable value. Listeners will also hear about the "AI Playground," a fast-track approach to testing AI tools.  This episode is packed with actionable insights and real-world examples to help you confidently navigate the world of AI. Leader Generation is hosted by Tessa Burg and brought to you by Mod Op. For an executive guide to growth and transformation, check out our book Getting Digital Done, now available on Amazon.   About Patty Parobek: As Vice President of AI Transformation, Patty leads Mod Op's AI practice group, spearheading initiatives to maximize the value and scalability of AI-enabled solutions. Patty collaborates with the executive team to revolutionize creative, advertising and marketing projects for clients, while ensuring responsible AI practices. She also oversees AI training programs, identifies high-value AI use cases and measures implementation impact, providing essential feedback to Mod Op's AI Council for continuous improvement. Patty can be reached on LinkedIn or at Patty.Parobek@ModOp.com.   About Tessa Burg: Tessa is the Chief Technology Officer at Mod Op and Host of the Leader Generation podcast. She has led both technology and marketing teams for 15+ years. Tessa initiated and now leads Mod Op's AI/ML Pilot Team, AI Council and Innovation Pipeline. She started her career in IT and development before following her love for data and strategy into digital marketing. Tessa has held roles on both the consulting and client sides of the business for domestic and international brands, including American Greetings, Amazon, Nestlé, Anlene, Moen and many more. Tessa can be reached on LinkedIn or at Tessa.Burg@ModOp.com.

The ALL ME® Podcast Navigating Today's Bodybuilding Landscape– Ron Harris Summary Ron Harris, an experienced bodybuilder and author, shares his journey in the bodybuilding industry and the importance of nutrition and training. He discusses the path to becoming a competitive bodybuilder, the role of genetics, and the use of performance-enhancing substances. Ron also opens up about his personal experience with using steroids and the short-term and long-term side effects. He emphasizes the need for education and awareness about the risks associated with these drugs. In this conversation, Ron Harris and Don Hooton discuss the dangers of performance-enhancing drugs in bodybuilding. They emphasize the importance of education. Ron shares his personal experiences and the risks associated with drug use, including the physical and mental side effects. They also discuss the influence of social media on young people and the need for more voices of reason in the fitness industry. Ron provides valuable insights and advice for those interested in bodybuilding and encourages a natural and informed approach to the sport. Takeaways ·        The bodybuilding industry requires dedication to training, nutrition, and consistency. ·        Genetics play a significant role in determining one's potential as a bodybuilder. ·        Proper nutrition, including a clean and well-timed diet, is crucial for achieving the desired physique. ·        Performance-enhancing substances, such as steroids, can enhance muscle growth and strength but come with short-term side effects and long-term health risks. ·        Education and awareness about the risks associated with performance-enhancing substances are essential for individuals considering their use. Education is crucial when it comes to the use of performance-enhancing drugs in bodybuilding. It is important to understand the risks and make informed decisions. ·        Social media influencers often promote the use of steroids without discussing the long-term health consequences. Young people should be cautious and seek reliable information. ·        The use of certain steroids, such as Tren, can have severe physical and mental side effects. It is not safe, especially for teenagers. ·        There is a need for more voices of reason in the fitness industry, particularly for younger individuals who may not relate to older experts. ·        Ron Harris emphasizes the importance of staying natural and prioritizing overall health and well-being in bodybuilding. ·        Access to information on social media can be both beneficial and harmful. It is essential to critically evaluate sources and seek reliable and experienced individuals for guidance. Chapters 00:00 Introduction and Background 03:22 The Evolution of the Bodybuilding Industry 05:51 Getting Started in Competitive Bodybuilding 08:31 The Importance of Nutrition in Bodybuilding 10:31 Performance-Enhancing Substances in Bodybuilding 14:26 Ron's Personal Experience with Steroids 20:10 Short-Term and Long-Term Side Effects of Steroid Use 23:06 The Impact on Health and the Need for Education 26:28 The Importance of Education and Responsible Use of Performance-Enhancing Drugs 28:11 The Influence of Social Media on Young People's Perception of Steroids 30:07 The Dangers and Side Effects of Tren and Other Steroids 37:36 The Need for More Voices of Reason in the Fitness Industry 42:58 Staying Natural and Prioritizing Health in Bodybuilding 46:56 Navigating the Information Landscape on Social Media Contact Ron Harris Email:  Instagram:  @ronharrismuscle https://linktr.ee/ronharris   Follow Us: Twitter: @theTHF Instagram: @theTHF Facebook: Taylor Hooton Foundation #ALLMEPEDFREE Contact Us:  Twitter: @theTHF Instagram: @theTHF Facebook: Taylor Hooton Foundation #ALLMEPEDFREE Email:  Phone: 214-449-1990 ALL ME Assembly Programs:

Norman Ohler, author of 'Tripped: Nazi Germany, the CIA, and the Dawn of the Psychedelic Age', discusses the history of drugs in Nazi Germany and the CIA's involvement with LSD. He shares his personal interest in drugs and the different types of drugs, as well as the cultural differences between Germany and the US. Ohler also talks about his father's use of LSD to help his mother with Alzheimer's and the legal issues they faced. The conversation delves into the CIA's experimentation with LSD and the manipulation of individuals, as well as Ohler's research process and the challenges of accessing archives. The conversation explores the discovery of LSD and its potential as a medicine, as well as the political and societal implications surrounding its use. It delves into the history of LSD, including its connection to Nazi Germany and the CIA. The discussion highlights the need for more research and understanding of psychedelics, and the potential benefits they may have in treating mental health conditions. The conversation also touches on the importance of set and setting when taking psychedelics, and the need for responsible use. Show Links  Get 1-month of FREE access to the ⁠Vet Collective Community⁠ by using discount code: NLT1UQTI  Join us here: ⁠⁠⁠https://www.collective.vet⁠⁠⁠   Episodes also available on Spotify, Apple, and Amazon Music.  https://linktr.ee/harder_not_smarterNorman's Linkshttps://www.normanohler.deChapters 00:00 Introduction and Background of the Guest 01:48 Drug Use in Nazi Germany and the Third Reich 06:38 Cultural Attitudes Towards Drugs in Germany and the US 09:36 LSD as a Medicine and its Potential Benefits 13:04 Legal Issues and Personal Use of LSD 16:16 The CIA's Experimentation with LSD and Manipulation 23:54 The Discovery of LSD and Its Potential as a Medicine 26:02 LSD's Connection to Nazi Germany and the CIA 29:05 The Need for More Research and Understanding of Psychedelics 31:19 The Importance of Set and Setting in Psychedelic Experiences 37:22 Responsible Use of Psychedelics Takeaways Drugs have always been a part of human history and society, and it is important to understand their effects and potential benefits. The cultural attitudes towards drugs differ between Germany and the US, with Germany being more conservative and less informed about psychedelics. LSD was initially developed as a medicine by a Swiss pharmaceutical company, and its potential therapeutic uses are still being explored. The CIA's involvement with LSD was driven by the fear of its use as a truth serum and the desire to manipulate individuals. Accessing archives and original sources is crucial for accurate historical research, but it can be challenging to find specific information. LSD was discovered by Albert Hoffman and initially developed by the pharmaceutical company Sandoz as a potential stimulant for the mind. The discovery of LSD led to research on its potential therapeutic benefits, including its use in treating depression and other mental health conditions. The political and societal climate of the time, including Nazi Germany and the Cold War, influenced the perception and regulation of LSD. There is a need for more research and understanding of psychedelics, including their potential benefits and risks, in order to make informed decisions about their use. Set and setting, as well as responsible use, are important factors to consider when taking psychedelics.

HSD recognizes the potential of Artificial Intelligence, or AI, to enhance learning for students and increase efficiency for educators. AI can empower students by aiding research, fostering idea development, and promoting engagement with schoolwork. For educators, AI's automation of time-consuming tasks enables a greater focus on instruction, mentorship, and building strong relationships with students. This rapidly evolving technology is already integrated into our daily lives, powering voice assistants, tailoring streaming recommendations, and curating social media feeds. AI's transformative power extends across diverse professional fields, from healthcare and finance to manufacturing and the creative arts, reshaping how we work and live. Understanding AI's capabilities and ensuring its responsible use is crucial to unlocking its full potential in education and preparing students for the future. Visit our website to learn more.  Our featured event is summer graduation! Congratulations are in order for eleven students from Glencoe High School, Hillsboro Online Academy, Liberty High School, and Oak Street Campus who completed their graduation requirements and were awarded their diplomas at a ceremony at Hidden Creek Community Center in mid-August in front of a full house of guests that included family and friends, Board members, and principals from the represented schools. Way to persevere, students! You make us Proud to be HSD! Hot News is produced and emailed to HSD families and staff each week school is in session. Please add the address to your “safe sender” list to make sure you always receive the latest issue. Please also bookmark our district website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠hsd.k12.or.us⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to stay informed about what's happening in our district and schools.

In this episode of the Ketamine Startup Podcast, we collaborate with Dr. Carl Bonnett, the founder of Klarisana and prior podcast guest, to explore the often misunderstood concept of ego death through the lens of Matthew Perry's experiences with ketamine therapy. The conversation also covers topics like the efficacy of ketamine in treating mental health conditions, near-death experiences induced by ketamine, and the crucial role of preparation and integration in ketamine therapy.Listen for a nuanced discussion that challenges preconceptions and sheds light on the therapeutic potential of ketamine when used responsibly. What You'll Learn in This Episode:• The Role of Media and Culture: How celebrity experiences can influence public interest and stigma surrounding psychedelic therapies.• Safety and Ethics in Ketamine Therapy: The importance of setting and professional oversight in ketamine treatments.• Personal Stories and Case Studies: Both Dr. Bonnett and Sam share anecdotes from their respective clinical practices, highlighting transformative experiences and common misconceptions.Episode 19 show notes:00:00 Episode Teaser - Ketamine & Near-Death Experiences00:23 Introduction00:31 Special Collaboration with Dr. Carl Bonnet01:52 Discussion on Matthew Perry and Ego Death02:36 Therapeutic Use of Ego Disruption05:39 Patient Experiences and Integration08:07 Safety and Responsible Use of Ketamine12:36 Education and Public Perception19:36 Concluding Thoughts and Final Remarks21:10 Additional Insights on Near-Death Experiences With SamThanks for listening - make sure to check out Dr. Bonnett's YouTube ChannelStudy mentioned in episode: Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports. Martial C, et al. Learn more about the types of ketamine experiences: The 4 Types of Non-Ordinary Experiences Your Ketamine Patients Can HaveConnect with Dr. Bonnett at:Instagram: docbonnett_psychedelicLinkedIn: /carlbonnettYouTube: @docbonnett⭐️ Want to fast track launching your ketamine clinic? If so, download our free checklist

Dr. Centor discusses the American College of Physicians' policy on the responsible use of artificial intelligence in health care with Ms. Nadia Daneshvar and Dr. Deepti Pandita.

Join us for an eye-opening conversation with Jerry Kaplan, a leading authority in artificial intelligence and a prolific entrepreneur, as we unpack the profound implications of generative A.I. Jerry, an adjunct lecturer at Stanford, dives into his motivations behind his latest book, "Generative Artificial Intelligence: What Everyone Needs to Know," stressing the necessity of understanding this fast-paced field. We dissect what generative A.I. is, the distinctions it holds from previous A.I. waves, and the vast potential it has in reshaping our interactions with technology and society at large. Throughout our discussion, we explore the seismic shifts generative A.I. is bringing to the job market and the broader workforce. From the evolution of work since the 1800s to contemporary changes, we see how technological advancements have altered job roles—sometimes displacing old ones while creating new opportunities. Generative A.I. stands poised to revolutionize creative and analytical tasks, even in software development, while underscoring the enduring importance of human empathy and personal interaction in a rapidly changing job landscape. We also delve into the rise of emotionally expressive A.I. and its societal impacts, from elder care to reducing political extremism. Jerry provides valuable insights into the concepts of A.I. hallucination and superintelligence, debunking myths and emphasizing the responsible use of A.I. technologies. Our conversation wraps up with a forward-looking perspective on the future of A.I. and society, highlighting the need to address wealth inequality and ensure the benefits of A.I. are widely distributed, fostering a more equitable and optimistic future. What You'll Learn: • What is Generative A.I. • How is Generative A.I. different from previous waves of A.I.? • The seismic disruptions from A.I. in the job market. • The rise of emotionally expressive AI and its impacts on society. • The innovative potentials and the ethical challenges we face with Generative A.I. • The critical importance of empathy in an A.I.-driven world. Podcast Timestamps: (00:00) – What is Generative Artificial Intelligence? (04:56) - Impacts of Generative A.I. (12:36) - Job Market Shifts Due to Automation (26:28) - Rise of Emotional A.I. Companions (41:00) – A.I. Hallucination and A.I. Superintelligence (52:14) - The Future of A.I. and Society More of Jerry: Jerry Kaplan is a distinguished Artificial Intelligence expert, serial entrepreneur, technical innovator, educator, and bestselling author. He holds a PhD in Computer and Information Science from the University of Pennsylvania, specializing in AI, and a BA from the University of Chicago. Kaplan has founded numerous technology startups, two of which became public companies, and has been a key contributor to the development of groundbreaking technologies such as tablet computers, smartphones, online auctions, and social computer games. Currently, he is an Adjunct Lecturer at Stanford University, where he teaches about the social and economic impact of AI. Kaplan's literary contributions include four influential books, with his latest, "Generative Artificial Intelligence: What Everyone Needs to Know," offering a comprehensive exploration of AI's evolving landscape. His work has earned him recognition in major publications and accolades such as the Ernst & Young Emerging Entrepreneur of the Year award. LinkedIn: https://www.linkedin.com/in/jerry-kaplan/ Key Topics Discussed: Positive Leadership, Artificial Intelligence, Generative A.I., Automation, Technological Advancements, Workforce Disruption, Emotional A.I., Superintelligence, Wealth Inequality, Responsible Use of Technology, A.I. Hallucination, Future of A.I., Ethics for Artificial Intelligence, Natural Language Processing More of Do Good to Lead Well: Website: https://craigdowden.com/ LinkedIn: https://www.linkedin.com/in/craigdowden/

In this episode of the "Vibe Science" podcast, hosts Ryan Alford and Chris Hanson interview Paul Austin, founder of Third Wave, about the evolving perceptions and therapeutic potential of psychedelics, with a focus on microdosing. Paul shares his personal journey and insights into the history and current landscape of psychedelics, discussing their medical applications and the societal stigma surrounding them. The conversation touches on recent legalization efforts, the impact of COVID-19 on mental health and psychedelic use, and the promising future of psychedelics in mental health treatment. Ryan and Chris emphasize the importance of open discussions about these substances.TAKEAWAYSEvolving perceptions of psychedelics and microdosingTherapeutic benefits of psychedelics for mental healthPersonal journeys and experiences with psychedelicsSocietal stigma surrounding psychedelic useRecent legalization efforts for psychedelics in various statesImpact of COVID-19 on mental health and psychedelic useHistorical context and evolution of psychedelic useImportance of safe and regulated therapeutic settingsMicrodosing as an accessible entry point for new usersFuture potential of psychedelics in mental health treatmentTIMESTAMPSIntroduction to Vibe Science (00:00:00)Introduction of the podcast, hosts Ryan Alford and Chris Hanson.Welcoming Paul Austin (00:00:36)Hosts welcome guest Paul Austin, founder of Third Wave, discussing his influence in the psychedelic space.Stigmatization of Psychedelics (00:01:35)Ryan shares his evolving views on psychedelics and their potential therapeutic benefits.Legalization Efforts (00:02:25)Paul discusses recent legalization of psilocybin mushrooms in Colorado and Oregon, and decriminalization in several cities.Historical Context of Psychedelics (00:05:13)Paul reflects on his journey with psychedelics and their historical use in society.The Third Wave Concept (00:06:14)Paul explains the concept of Third Wave, integrating ancient and modern perspectives on psychedelics.Psychedelics vs. Traditional Drugs (00:14:36)Discussion on the safety and potential of psychedelics compared to traditional substances like alcohol and tobacco.Cultural Shifts and Milestones (00:16:56)Paul outlines key milestones in the psychedelic movement, including Michael Pollan's influential book.Impact of COVID-19 (00:18:59)The pandemic increased psychedelic use and interest in mental health treatments, including ketamine therapy.Future of Psychedelics (00:20:05)Paul predicts widespread legal access to psychedelics in the coming years, driven by public support and clinical research.Personal Journey with Psychedelics (00:22:20)Paul shares his personal experience with psychedelics and their impact on processing emotions.Advocacy for Psychedelics (00:23:20)Paul discusses his strong belief in psychedelics as powerful tools for emotional and spiritual healing.Understanding Different Substances (00:24:26)Paul explains the various psychedelics and their distinct experiences, emphasizing the importance of substance choice.Therapeutic Use of Ketamine (00:27:19)The therapeutic applications of ketamine are discussed, including its benefits for depression and suicidality.Risks of Ketamine Use (00:28:36)Paul highlights the dangers of unsupervised ketamine use and the importance of a safe therapeutic setting.Microdosing Benefits (00:29:57)Microdosing benefits are outlined, focusing on improved mood, energy, and sleep without significant intoxication.Ketamine Therapy Experience (00:30:30)Discussion on whether patients talk during ketamine therapy sessions, depending on the dosage used.Navigating Emotional Release (00:32:29)The conversation addresses the balance between emotional vulnerability and resilience, especially for men.Mindset and Psychedelics (00:34:02)Paul emphasizes the importance of mindset when using psychedelics for personal development and resilience.Personal Development vs. Recreational Use (00:36:30)The distinction between using psychedelics for personal growth versus recreational enjoyment is explored.Self-Regulation and Responsibility (00:38:32)The need for self-regulation in substance use is discussed to avoid dependency.Starting with Psychedelics (00:39:58)Paul advises beginners on how to approach psychedelics safely and responsibly, starting with microdosing.Credibility in Psychedelic Discussions (00:42:01)Ryan praises Paul for his in-depth knowledge and credible approach to discussing psychedelics.Resources for Learning More (00:42:56)Paul shares where listeners can find more information about psychedelics and microdosing through Third Wave.Personal Contact Information (00:43:17)Paul shares his social media handles for listeners to reach out with questions.Appreciation and Credibility (00:43:30)Ryan expresses gratitude for Paul's insights and credibility during the episode.Acknowledgment of Hosts (00:43:37)Paul thanks Ryan and Chris for their contributions and sharing their stories.Excitement for Episode Release (00:43:44)Chris shares his enthusiasm for the episode's release and its potential impact on listeners.Episode Summary and Resources (00:43:51)Ryan provides information on where to find episode highlights, full episodes, and guest resources.Medical Disclaimer (00:44:04)Ryan emphasizes that the content is for educational purposes and not medical advice.Closing Remarks (00:44:12)Ryan thanks listeners and encourages them to visit the podcast website for more information. Follow us on Instagram: @Vibe.Science Subscribe to our YouTube Page: www.youtube.com/@Vibe.Science

In this special episode, listen in on a panel from AWS Summit Washington DC 2024, featuring: Elizabeth Kelly, Director, US AI Safety Institute, National Institute of Standards & Technology; Rep. Ami Bera, M.D. , U.S. House of Representatives; Michael Sellitto, Head of Global Affairs, Anthropic; Dr. Radha Plumb, Chief Digital and Artificial Intelligence Officer, Department of Defense; and Olivia Igbokwe, Head of Federal Affairs and Federal AI, AWSLeaders from government and industry discuss the rapid advancements in generative AI technology and the critical need to ensure its responsible development and use. Experts explore the opportunities AI presents, such as improved healthcare and national security, as well as emerging challenges around mitigating risks like disinformation and misuse. The conversation highlights the importance of public-private partnership, global coordination, and iterative research to advance AI safety and enable ethical innovation.

Here it is: Six Pixels of Separation - The ThinkersOne Podcast - Episode #940. I've had his brother (Don Tapscott) and nephew (Alex Tapscott) on the show countless times. We might as well extend the invitation to Bob Tapscott. Bob has a knack for diving into the deep end of tech and coming up with pearls of wisdom. With a background as a CIO, speaker, and consultant, Bob's journey spans nuclear power maintenance, Wall Street derivatives, and flying commercial aircrafts by computer. He's the go-to guy for developing and implementing disruptive strategies that actually work, focusing on corporate performance and customer satisfaction (meaning: He's the person that is building the tech we all talk about). Bob delves into what he calls the second era of computing - where computers don't just follow orders, they learn, ask questions and show us what we need. It's a “game-changer” (and I hate that word!), driven by the convergence of artificial intelligence (AI), blockchain, and the Internet of Things (IoT). Bob breaks it down: We're seeing an growth in computing power that's reshaping our world. AI isn't just about making things faster - it's about making things smarter. The company with the most data will have the smartest systems, and that's a big deal. But with great power comes great responsibility (thanks, Uncle Ben!). We talk about the potential for job displacement and the societal challenges that come with these advancements. It's not just about the tech... it's about the frameworks we need to guide its implementation responsibly. Our conversation touches on the exciting and somewhat daunting possibilities of AI, like the development of generative AI tools and the role of startups in this evolving landscape. Bob is particularly keen on the ethical implications - how do we ensure these technologies benefit society as a whole? And let's not forget the international angle. Tech doesn't respect borders, so collaboration is key. Bob's new book, Trivergence - How Ai, Blockchain, And The Internet Of Things Are Ushering In A New Digital Age, is all about navigating this brave new world. He explores the synergies between AI, blockchain, and IoT, showing how these technologies can work together to transform business and society. It's not a tech manual... it's a guide for making smart decisions in a world full of uncertainties. Bob talks about the power of Infinite Data - where AI, powered by vast datasets, can generate insights and value without human intervention. It's fascinating and a must-read for anyone looking to stay ahead of the curve. Bob unpacks these concepts with a mix of technical insight and practical wisdom. Whether you're a tech enthusiast or a business leader, there's something here for you. Enjoy the conversation... Running time: 1:04:20. Hello from beautiful Montreal. Subscribe over at Apple Podcasts. Please visit and leave comments on the blog - Six Pixels of Separation. Feel free to connect to me directly on Facebook here: Mitch Joel on Facebook. Check out ThinkersOne. or you can connect on LinkedIn. ...or on Twitter. Here is my conversation with Bob Tapscott. Trivergence - How Ai, Blockchain, And The Internet Of Things Are Ushering In A New Digital Age. Follow Bob on LinkedIn. Follow Bob on X. This week's music: David Usher 'St. Lawrence River'. Takeaways The second era of computing is characterized by computers being able to ask and learn, rather than just being programmed. The exponential growth in computing power, driven by blockchain and AI, is transforming society. Data is crucial for AI development, and the company with the most data will likely have the most intelligent system. The implementation of AI and other technologies could lead to job displacement and societal challenges. Thoughtful frameworks and discussions are needed to guide the responsible and beneficial use of these technologies. The development of AI tools like chat GPT is impressive and has the potential to outperform human capabilities in certain tasks. The growth of data is exponential, and it presents both opportunities and challenges in the field of AI. The consolidation of AI power among big tech companies is likely, but startups can still find success by focusing on specific domains. The ethical implications of AI, including autonomous killing machines, raise concerns and the need for careful regulation and oversight. The impact of AI is not limited by geographic borders, and international collaboration is crucial for addressing its challenges and maximizing its benefits. Chapters: 00:00 - Introduction and Background. 09:49 - Exponential Growth in Computing Power. 25:38 - Guiding the Responsible Use of Technology. 35:20 - Exploring the Potential of AI: Open AI and Generative AI Tools. 45:47 - The Exponential Growth of Data and its Implications for AI. 53:12 - Startups in the AI Landscape: Focusing on Specific Domains. 01:00:06 - The Role of Geography and the Need for International Collaboration in AI.

Episode Description: Karl and Erum are exploring the world of modern probiotics with Zack Abbott, co-founder of Z Biotics. They discuss the innovative approach Z Biotics takes in engineering probiotics to offer tangible benefits, specifically focusing on their flagship product designed to alleviate the unpleasant after-effects of alcohol consumption. Zack shares a look into the science behind their probiotic, explaining how it breaks down toxic byproducts in the gut, thereby improving the next-day experience after drinking. The conversation also touches on the broader implications of genetically modified organisms (GMOs) in consumer products, challenging common misconceptions and tells the potential for biotechnology to enhance everyday health solutions. You'll definitely leave this episode with a deeper understanding of both the potential and the responsible use of GMOs in creating products that not only solve real-world problems but also pave the way for more informed and nuanced discussions about biotechnology. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing? Learn more at ⁠⁠www.messaginglab.com/groweverything⁠⁠ Chapters: 00:00:00 - Debunking the Anti-GMO Myth 00:00:29 - Karl and Erum: Sneaker Trends and Fashion Observations 00:02:37 - 4th of July Plans and Summer Adventures 00:05:17 - Ginkgo Bioworks Restructuring 00:07:28 - The Debate on Synthetic Vitamins 00:13:07 - Introducing Zack Abbott 00:15:00 - Origin Story and Inspiration Behind Z Biotics 00:17:00 - The Science of Alcohol Metabolism 00:21:00 - How Z Biotics Works in the Gut 00:23:00 - Engineering Safe and Effective Probiotics 00:27:00 - Ensuring Compatibility with Human Microbiomes 00:29:00 - Addressing Consumer Skepticism 00:31:00 - The Role of Transparency in GMO Products 00:33:00 - Public Perception and Marketing Strategies 00:34:39 - Exploring the Benefits of Prebiotics 00:35:03 - Ensuring Safety and Efficacy 00:36:35 - Market Launch and Consumer Feedback 00:38:51 - Public Perception of GMOs 00:41:50 - Advocating for Genetic Engineering 00:45:16 - Future Applications and Product Development 00:46:09 - Responsible Use of Biotechnology 00:54:21 - The Role of Biotechnology in Consumer Health 00:57:29 - Advice for Aspiring Biotech Entrepreneurs 00:59:42 - Final Thoughts and Reflections Topics Covered: biotech, bioengineering, microbiology, gut microbiome, consumer biotech, prealcohol, oral microbiome, entrepreneurship, acetaldehyde, alcohol, next day effects. Episode Links: Enter to win free Oobli Chocolate  Zbiotics: https://zbiotics.com/  Lumina Oral Biotic: https://www.luminaprobiotic.com/  K18 Hair: https://www.k18hair.com/ Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowEverything website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email: groweverything@messaginglab.com Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

In this podcast episode, Diana and Nicole discuss the evolving role of AI chatbots in various writing contexts, particularly in academia and genealogy. They highlight the changing policies around the use of large language models (LLMs) in academic writing, noting how organizations like the International Conference on Machine Learning have shifted from prohibiting to allowing LLMs, provided that authors are responsible for the content and its integrity. They delve into the ethical considerations of using AI in genealogy writing, especially for projects that are meant for accreditation or professional certification. They stress the importance of originality and caution against claiming AI-generated work as one's own, citing ethical guidelines that discourage taking credit for others' contributions, including those made by AI. Nicole created this summary with ChatGPT 4. Links Disclosing Use of AI for Writing Assistance in Genealogy - https://familylocket.com/disclosing-use-of-ai-for-writing-assistance-in-genealogy/ Program Chairs for the International Conference on Machine Learning, “ICML 2024,” icml.cc, 2024, https://icml.cc/Conferences/2024/CallForPapers. See also Program Chairs for the International Conference on Machine Learning, “International Conference on Machine Learning (ICML) 2023,” icml.cc, 2023, https://icml.cc/Conferences/2023/llm-policy. Mohammad Hosseini, David B Resnik, and Kristi Holmes, “The Ethics of Disclosing the Use of Artificial Intelligence Tools in Writing Scholarly Manuscripts,” Research Ethics 19, no. 4 (June 15, 2023): 449–65, https://doi.org/10.1177/17470161231180449. Gregory E Kaebnick et al., “Editors' Statement on the Responsible Use of Generative AI Technologies in Scholarly Journal Publishing,” Hastings Center Report 53, no. 5 (September 1, 2023): 3–6, https://doi.org/10.1002/hast.1507. Lindsey Passenger Wieck, “Revising Historical Writing Using Generative AI: An Editorial Experiment,” www.historians.org, August 15, 2023, https://www.historians.org/research-and-publications/perspectives-on-history/summer-2023/revising-historical-writing-using-generative-ai-an-editorial-experiment. Sponsor – Newspapers.com For listeners of this podcast, Newspapers.com is offering new subscribers 20% off a Publisher Extra subscription so you can start exploring today. Just use the code “FamilyLocket” at checkout.  Research Like a Pro Resources Airtable Universe - Nicole's Airtable Templates - https://www.airtable.com/universe/creator/usrsBSDhwHyLNnP4O/nicole-dyer Airtable Research Logs Quick Reference - by Nicole Dyer - https://familylocket.com/product/airtable-research-logs-for-genealogy-quick-reference/ Research Like a Pro: A Genealogist's Guide book by Diana Elder with Nicole Dyer on Amazon.com - https://amzn.to/2x0ku3d 14-Day Research Like a Pro Challenge Workbook - digital - https://familylocket.com/product/14-day-research-like-a-pro-challenge-workbook-digital-only/ and spiral bound - https://familylocket.com/product/14-day-research-like-a-pro-challenge-workbook-spiral-bound/ Research Like a Pro Webinar Series 2024 - monthly case study webinars including documentary evidence and many with DNA evidence - https://familylocket.com/product/research-like-a-pro-webinar-series-2024/ Research Like a Pro eCourse - independent study course -  https://familylocket.com/product/research-like-a-pro-e-course/ RLP Study Group - upcoming group and email notification list - https://familylocket.com/services/research-like-a-pro-study-group/ Research Like a Pro with DNA Resources Research Like a Pro with DNA: A Genealogist's Guide to Finding and Confirming Ancestors with DNA Evidence book by Diana Elder, Nicole Dyer, and Robin Wirthlin - https://amzn.to/3gn0hKx Research Like a Pro with DNA eCourse - independent study course -  https://familylocket.com/product/research-like-a-pro-with-dna-ecourse/ RLP with DNA Study Group - upcoming group and email notification list - https://familylocket.com/services/research-like-a-pro-with-dna-study-group/ Thank you

What does AI and electricity have in common? Joe Velderman, Vice President of Innovation at Cypress Living, shares insights on consumer technology expectations and practical application of artificial intelligence in aging services. Plus, how sales and marketing in senior living is directly impacted by tech.Free resource: Responsible Use of AI in Aging Services Produced by Solinity Marketing.Become a sponsor of Bridge the Gap.

At their February 2024 meeting, Allied Defence Ministers formally adopted NATO's Biotechnology and Human Enhancement Technologies Strategy. Current NATO staff driving the development and delivery of this Strategy outline one of its main features: the first-ever set of Principles of Responsible Use for Biotechnology and Human Enhancement technologies in defence and security.

This episode of Mathematica's On the Evidence podcast features a discussion about how various parties within the health care ecosystem can responsibly use artificial intelligence (AI) to improve patient health. The conversation comes amid increasing interest in the applications of AI in daily life and one month after Mathematica announced the launch of its Health Data Innovation Lab, a digital operational hub for government agencies, foundations, medical centers, and other health organizations to collaborate with data scientists and health policy experts. The episode draws from a recent webinar moderated by Noland Joiner, the chief technology officer of health care at Mathematica, with Ngan MacDonald and Ellie Graeden as guests. MacDonald is the director of health data innovations at Mathematica and Graeden is a partner and chief data scientist at Luminos.Law. She is also an adjunct research professor at Georgetown University. A transcript of the episode is available here: https://www.mathematica.org/blogs/improving-health-through-responsible-ai Learn more about Mathematica's Health Data Innovation Lab: https://www.mathematica.org/sites/health-data-innovation-lab

In this episode we dive into issues of human-machine teaming, with human factors engineer Jan Maarten Schraagen. Having edited the recently released book, Responsible Use of AI in Military Systems, Jan Maarten is an expert on how brittle technologies influence joint cognitive system performance. In this episode, in addition to exploring the book, we explore the outcomes of the 2023 REAIM Summit and what we can hope for from the 2024 Summit;  talk about multidisciplinarity in the responsible military AI debate; and how we should be thinking about capability envelope of military AI - that is, how it can or should be restricted in the conditions under which it can operate. Jan Maarten Schraagen is a cognitive systems engineer at TNO, and studies how brittle technologies influence joint cognitive system performance. He is a human factors specialist with broad experience in optimizing work processes and teamwork design. He is particularly interested in making work safe, productive and healthy, and improving resilience in sociotechnical work systems.Additional resources:Jan Maarten Schraagen (ed), Responsible Use of AI in Military Systems, CRC Press, 2024Ekelhof, M.A.C. (2018). Lifting the Fog of Targeting: “Autonomous Weapons” and Human Control through the Lens of Military Targeting. Naval War College Review, 71(3), 61-94.Ekelhof, M.A.C. (2019). Moving beyond semantics on autonomous weapons: Meaningful human control in operation. Global Policy, 10(3), 343-348.Endsley, M.R. (2017). From here to autonomy: Lessons learned from human-automation research. Human Factors, 59(1), 5-27.Taddeo, M., & Blanchard, A. (2022). A comparative analysis of the definitions of autonomous weapons systems. Science and Engineering Ethics, 28, 37-59.Herbert Simon, Bounded Rationality, Utility and Probability, NPA, 1990Peeters, M.M.M., van Diggelen, J., van den Bosch, K., Bronkhorst, A., Neerincx, M.A., Schraagen, J.M., Raaijmakers, S. (2021). Hybrid collective intelligence in a human–AI society. AI and Society, 36(1), 217-238.Schraagen, J.M.C., Barnhoorn, J.S., Van Schendel, J., & Van Vught, W. (2022). Supporting teamwork in hybrid multi-team systems. Theoretical Issues in Ergonomics Science, 23(2), 199-220.Van der Kleij, R., Schraagen, J.M.C., Cadet, B., & Young, H.J. (2022). Developing decision support for cybersecurity threat and incident managers. Computers & Security, 113, 102535.Schraagen, J.M.C. (2023). Responsible use of AI in military systems: Prospects and challenges. Ergonomics, 66(11), 1719 – 1729.

Dr Sue Morter is a Master of Bio-Energetic Medicine, reveals The Energy Codes® and the hidden power behind Kundalini energy and healing. Quantum Field visionary. Dr. Sue also created the BodyAwake® RYT 200 Certified Yoga Program and is co-creator of the Bio-Energetic Synchronization Technique (B.E.S.T.) Dr. Sue Morter has opened the doors to her HEAL YOURSELF HEAL YOUR LIFE: The Future of Wellbeing program. In this program, you will learn the energy techniques to skyrocket to greater health, clarity and purpose.

An insight into my thoughts this week

At NAB Show in Las Vegas, Jim Tierney, Chief Executive Anarchist at Digital Anarchy, demonstrated the latest addition to their Beauty Box software. This time, Beauty Box adds the ability to whiten teeth in your video. Jim also introduces the concept of “digital makeup”, provides some thoughts on the state of AI in video production, and why it might not be quite as far along as you might think.  Show Notes: Chapters: 01:01 Introduction to Beauty Box 6.0. 01:47 Challenges of AI in Beauty Box. 02:51 Effects of Beauty Box on footage. 04:30 Purpose of Digital Makeup. 05:13 Authenticity vs. Digital Makeup. 05:45 Taboo around Digital Makeup. 06:57 Default Settings in Beauty Box. 08:12 Release Date for Beauty Box 6.0. 09:14 Impact of AI in the Industry. 10:26 Misconceptions about AI. 11:40 Limitations of AI in Content Generation. 12:56 AI's Future Evolution. 13:31 Responsible Use of Practical AI Guests: Jim Tierney is a pioneer in the development of plugins for motion graphics, animation and video editing. During the 1990's, Jim worked for software companies like MetaTools, Atomic Power and Cycore. He helped create graphics products like Bryce, Evolution and Final Effects. After working on After Effects plugins for six years, Jim thought it was finally time to get out there and do some of his own. So he did, and Digital Anarchy was born in 2001. Connect with them on Facebook and Twitter, and follow Jim himself on Twitter. Support:      Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:      http://macvoices.com      Twitter:      http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices      Mastodon:      https://mastodon.cloud/@chuckjoiner      Facebook:      http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:      http://www.facebook.com/macvoices/      MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice      LinkedIn:      https://www.linkedin.com/in/chuckjoiner/      Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

In this episode of the Neuroflex Podcast, host Toby Paspitt interviews Dr. Julia Muirer, a consultant in psychedelic medicine, about her journey from pediatrics to psychedelics, the transformative potential of these substances, and the importance of integrating them responsibly into healthcare. Dr. Muirer discusses the contrasts between her expectations of the medical field and her actual experiences, leading to her departure from traditional medicine to explore alternative healing modalities. Highlighting the transformative effects of psychedelics such as psilocybin and ketamine, she details her own psychedelic experiences that guided her career pivot. Dr. Muirer advocates for education and responsible use of psychedelics, addressing the need for proper support systems, integration, and a holistic approach to patient care. She also touches on the challenges of 'bad trips' and the power of psychedelics to deepen one's connection to inner wisdom, emphasizing the value of personal insights and gradual change. The conversation concludes with ways to connect with Dr. Muirer and her work in the emerging field of psychedelic medicine.00:00 Introduction to the Episode and Guest00:13 Dr. Julia Meir's Journey from Pediatrics to Psychedelic Medicine00:57 The Pivot to Psychedelic Medicine and Personal Transformation03:30 Exploring the Psychedelic Experience and Its Impact07:43 The Responsible Use and Marketing of Psychedelics18:22 Psychedelic Therapy: Setting, Process, and Integration25:03 Nushama: A Unique Approach to Psychedelic Wellness34:43 Understanding 'Bad Trips' and the Power of Processing40:14 Connecting with Dr. Julia Meir and Closing ThoughtsConnect with Julia⬇️⬇️⬇️Instagram: https://www.instagram.com/mirernotes/LinkedIn: https://www.linkedin.com/in/jmirermd/Facebook: https://www.facebook.com/julia.mirer.7

An underutilized superpower of generative AI? The way it can completely change how research is done. So how is AI impacting academic and scientific research and what tools are out there to help? Avi Staiman, Founder of sciwriter.ai, joins us to discuss AI tools to supercharge your research. Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Ask Jordan and Avi questions on AI and researchRelated Episodes:Ep 89: AI's Role in Responsible ResearchEp 121: Faster and More Accurate Results From ChatGPT with ScholarAIUpcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: info@youreverydayai.comConnect with Jordan on LinkedInTimestamps:01:20 Daily AI news05:16 Simplify writing process for academic researchers with AI.07:36 Democratization of science and skepticism in society.10:33 ChatGPT has diverse data sources, impacts reliability.18:36 AI researchers responsible for high standard, education.19:32 Using AI in research22:37 AI tools improving accessibility and accuracy.27:30 Explore pain points, offer AI research tools.31:17 Questioning scientific studies, AI's importance emphasized.35:05 Encourage critical thinking when using AI tools.37:18 AI can enhance research and understanding information.Topics Covered in This Episode:1. Importance of Research Accessibility and Transparency2. Utilizing AI Tools in Research and Writing3.  Integrity and Reliability of AI-Generated Content4. Responsible Use of AI and Source Attribution5. Problems of AI-generated Content in ResearchKeywords:skepticism around science, accessibility in research, transparency in research, AI tools, democratization of research, research integrity, research reliability, research fraud, misuse of AI tools, scientific literature, attribution in research, Jordan Wilson, ChatGPT, Sykespace, Illicit, Sciwriter, academic writing, AI Tool Up Tuesdays, curated content, Everyday AI, academic research, CodeRepair, Stable Audio 2.0, peer-reviewed journal article, publish or perish pressure, Consensus Scholar AI, Perplexity, Proofig, Image Twin. Get more out of ChatGPT by learning our PPP method in this live, interactive and free training! Sign up now: https://youreverydayai.com/ppp-registration/

Welcome to an empowering episode of the Building Men Podcast where we dive deep into the remarkable story of Mike 'C-Roc' Ciorrocco. I'm your host, Dennis Morolda, and in this episode, we discuss the art of transforming adversity into triumph and the strategies for entrepreneurial success. We uncover Mike's inspiring journey, his approach to resilience, and his blueprint for converting pain into purpose. Whether you're a young man navigating life's challenges or an entrepreneur seeking growth, this conversation is a must-listen. Episode Highlights: 1. The Impact of Mindset on Young MenMike 'C-Roc' Ciorrocco opens up about his experiences as a straight-A student and athlete turned thought leader. He discusses the metaphor of the 'hooptie' car, representing the emotional burdens we carry, and the importance of converting life's challenges into propulsion for personal growth. The chapter emphasizes the role of mentorship in shaping the futures of young men. 2. Overcoming Childhood Trauma and Family InstabilityMike shares his personal struggles with his parents' divorce and living with his father, which led to a moment that ignited his determination to succeed. He explains his concept of 'rocket fuel' – using adversity as motivation to drive forward and the realization that we always have the power to change our circumstances. 3. Evolution of Male Relationship DynamicsMike delves into his changing perspective on traditional gender roles and the importance of core values and responsibility in personal growth. He reflects on the influence of role models and mentors in his life and the importance of aligning with the right people to foster leadership and success. 4. Embracing Identity and Responsible Use of TechnologyThe importance of owning your identity and using technology wisely to make a mark in the world is discussed. Mike stresses the significance of getting known for your talents and sharing your journey authentically on social media to build a supportive network. 5. Strategies for Business SuccessMike unpacks the essentials for iterating on business ideas, documenting successful processes, and scaling ventures. He recommends resources for personal and professional growth and encourages listeners to clearly define and pursue their goals to witness the magic of their aspirations coming to life. Connect with Mike 'C-Roc' Ciorrocco:Don't miss the opportunity to continue this conversation with Mike across social platforms. Reach out for an expanded dialogue on personal growth and professional success. Listen to this episode for an insightful look into how adversities can be transformed into a driving force for achieving your dreams. Mike 'C-Roc' Ciorrocco's story is not just a testament to the power of resilience but also a guiding light for those looking to create their own path to triumph. Get in Touch with Mike: https://www.instagram.com/mikeycroc/ Book a call at That1Agencywww.that1agency.com Consulting Session via Intro Apphttps://intro.co/MikeC-RocCiorrocco  THE FOUNDATION - Virtual Community for Young MenBuilding Men InstagramBuilding Men WebsiteBuilding Men YouTubeBuilding Men FacebookWork with Dennis as your 1 on 1 coach If our podcast resonates with you, please consider rating, reviewing and sharing it with anyone who you believe would benefit from the message.Visit our sponsors - Finish The Race – Home of the official Building Men gear

In this 161st episode, I share my daily reflection posted on Twitter @bryoncar, from March 4th to 8th, 2024 Check out the WHOLE SPOTIFY PLAYLIST I put together with all the listens mentioned below: >>> bit.ly/FreshAirAtFiveSpotifyPlaylistE161

In this episode of Fundraising AI Podcast,  Join our hosts, Nathan and Scott, in a captivating discussion as they unravel the multifaceted relationship between humanity and artificial intelligence (AI). In this engaging conversation, they traverse various themes surrounding the utilization of AI tools, exploring both their practical applications and ethical implications.  Throughout the dialogue, Nathan and Scott explore the spectrum of AI tools, from the novelty of emerging technologies to the integration of established platforms like OpenAI and Co-Pilot into daily workflows. They share personal experiences and insights into how different AI tools cater to specific needs, whether it's for productivity, research, or creative endeavors. The conversation also delves into the mindset shift required to fully leverage AI's potential while ensuring responsible usage. They discuss the importance of understanding the limitations and risks associated with AI, highlighting the need for organizations to foster a culture of experimentation and learning.  As the discussion unfolds, Nathan and Scott reflect on the balance between efficiency and authenticity in AI-driven interactions. From personalized AI-generated content to the enduring value of face-to-face communication, they explore how AI intersects with human emotions and experiences. Ethical considerations surrounding AI usage are also examined, focusing on the imperative of promoting beneficial and responsible AI practices. Nathan and Scott emphasize the need for transparency, accountability, and informed decision-making in harnessing the power of AI for societal benefit. In closing, they contemplate the evolving role of AI in content creation and personalization, pondering its implications for digital engagement and human connection. Episode Highlights   [03:45] Arc Browser: A Revolutionary Tool or a Pandora's Box?  [08:07] OpenAI, Perplexity, and Co-Pilot in Focus  [10:12] Overcoming Mental Blocks and Embracing the AI Mindset  [12:40] Shift from Google to Generative AI  [14:01] Overcoming Resistance and Enhancing Efficiency  [20:22] The Importance of Embracing AI in Organizations  [21:33] Era of Beneficial and Responsible AI: Welcoming Innovation with Caution  [23:31] Leveraging AI for Personalization Amidst Digital Overload  [25:35]The Heartfelt Blend of Digital and Personal: AI in Human Connections  Resources:  Connect with Nathan and Scott:  LinkedIn (Nathan): linkedin.com/in/nathanchappell/  LinkedIn (Scott): linkedin.com/in/scott-rosenkrans  Website: fundraising.ai/ 

In this episode Jen talks with Eric Curts about his take on AI in Education including the benefits, concerns, bias and more. http://ShukesAndGiff.com #ShukesAndGiff

In this episode, host Josh Hirsch discusses the power of AI in nonprofits with guest Cherian Koshy. They explore Cherian's journey into AI and how it can be used to make nonprofits more efficient and effective. They also discuss the steps to getting started with AI and the future of AI integration in the nonprofit sector. They emphasize the importance of responsible use of AI and transparency in its implementation. In the Coaches Corner segment, Jacob Wenge shares insights on building a sustainable volunteer program.TakeawaysAI has the power to make nonprofits more efficient and effective.Getting started with AI involves aligning values, defining goals, and exploring different tools.Responsible use of AI requires transparency and ethical considerations. AI Usage Policy: https://resources.workable.com/ai-tool-usage-policyBuilding a sustainable volunteer program involves defining goals, aligning expectations, and empowering volunteers.Chapters00:34 The Power of AI in Nonprofits05:25 The Impact of AI on Jobs07:50 Using AI for Efficiency and Effectiveness08:18 Steps to Getting Started with AI09:45 Building Trust and Aligning Values10:37 The Future of AI Integration13:29 Responsible Use of AI14:55 Transparency and Disclosure37:55 Coaches Corner: “What are the Best approaches on building a sustainable volunteer program?” Guest BioCherian Koshy is a Certified Fundraising Executive (CFRE), Chartered Advisor in Philanthropy (CAP), & AFP Master Trainer. He founded the NonprofitOS, a generative AI platform designed to help organizations maximize their impact, which was acquired by iWave. Before starting NonprofitOS, Cherian spent more than 25 years working in the nonprofit sector, working with thousands of donors and raising more than 100 million for various organizations and causes. He proudly serves as the Vice Chair of Professional Development on the AFP Global Board. He is a sought-after trainer and keynote speaker, and his thought leadership has been featured in several publications.Like this episode? Subscribe to our podcast on Apple, Spotify, or your favorite podcasting app. Leave a review! Reviews are hugely important because they help new people discover this podcast. If you enjoyed listening to this episode, please leave a review.Got a question that you'd like to ask a nonprofit professional? Email your questions to IMPACTcoaches@IMPACTability.net and listen to next episode to see if your question gets answered!This podcast uses the following third-party services for analysis: Chartable - https://chartable.com/privacy

Responsible use and governance of AI are key issues today, as training data limitations and data retention issues must be addressed. The risk of exposing PII or other confidential data, managing bias, hallucination, misinterpretation risks and other AI considerations are discussed. Fitzgerald, T. 2019. Chapter 4: Emerging Technologies and Trends in CISO COMPASS: Navigating Cybersecurity Leadership Challenges with Insights from Pioneers, 1st Ed, pg 89-125. Fitzgerald, T. CRC Press, Boca Raton, Fl. www.amazon.com/author/toddfitzgerald. This segment is sponsored by Darktrace. Visit https://cisostoriespodcast.com/darktrace to learn more about them! Visit https://cisostoriespodcast.com for all the latest episodes! Show Notes: https://cisostoriespodcast.com/csp-162

Overview: In this thought-provoking episode of "Daily Alchemy," humorously referred to as "Monthly Alchemy" by host Sean Clayton, listeners are invited into a reflective journey. Sean discusses his recent experiences and insights, touching on topics like psionic Ascension codes, the significance of the winter solstice, and sharing his journey through Instagram updates. Key Highlights: Collaborative Ventures: Sean announces an upcoming collaborative podcast centered on "Alchemy, Abundance, and Ascension." The collaboration aims to delve into life optimization, shadow work, and related themes. Understanding Ascension: Sean explores the concept of Ascension, emphasizing the balance of light and darkness. He talks about the importance of earning and recognizing one's own worth. Abundance is framed as a journey of embracing one's worthiness. Philosophy of Communication and Observation: Sean advises on the value of speaking less and observing more. He stresses the importance of internal change over trying to alter external perceptions. Responsible Use of Power: The episode discusses the responsible use of spiritual and personal gifts. Sean cautions against the ego-driven misuse of attributes like sexuality or spiritual prowess. Numerology Insights: The Eight and Nine: Eight: Associated with expansiveness and co-creation, transcending individualism to embrace a collective perspective. Nine: Represents completion, the concept of 'eternally unborn,' symbolizing life's cycle and transcendence. Personal and Collective Growth: Sean encourages acknowledging the interconnectedness of all life. He emphasizes the importance of understanding reality and existence from a holistic perspective. Future Episode Plans: Sean commits to more consistent podcasting and plans to integrate video content. Future episodes will explore deeper esoteric principles and personal initiation.

On this week's Technology Report, John CoFrancesco, the founder of Applied AI Company, discusses the Biden administration's new executive order to ensure safe, secure and trustworthy artificial intelligence, efforts to use the“Political Declaration on the Responsible Use of Artificial Intelligence and Autonomy” as a foundation for a global standard, why fear of the technology is misplaced, the implications of the SEC's suit against SolarWinds' CISO, countering cyber and social efforts by Iran as well as its allies China and Russia, and outlook for constraining irresponsibility of social media firms with Defense & Aerospace Report Editor Vago Muradian.

Facts Not Feelings dives deep into the automotive industry's latest trends in this special Digital Dealer Vegas episode. Join host Brooke Furniss and esteemed guests, including Mike Bukowski, "Big" Al Gillespie, Mike Colacchio, and Allie Peters. Uncover the mysteries of Google Analytics 4 (GA4), the balance between Organic vs. Paid strategies, the evolving landscape of Fixed Ops, and the promising horizon of AI & Chat GPT in automotive. Be part of the discussion that highlights the role of CDPs in ensuring data privacy and the captivating evolution of personalized marketing. Subscribe now and stay ahead in the automotive industry!Key Takeaways:1. GA4 provides much more granular and customizable reporting through its event-based structure and parameters. 2. Proper setup of access controls is critical to avoid wrecked reporting. Limit admin and edit access. 3. Linking website activity to sales is easier in GA4 if you build out custom events, dimensions and metrics tailored to your dealership's needs.Connect

After many years of people saying, “AI can never be creative, AI could never write fiction (i.e. make things up), it's now evident that the generative AI tools make a lot up — and we need to be aware of the potential ramifications. How can we use the tools to achieve our creative purpose in […] The post The Tsunami Of Crap, Misinformation, And Responsible Use Of AI With Tim Boucher first appeared on The Creative Penn.